<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:07:14Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9288513" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9288513</identifier>
        <datestamp>2022-10-14</datestamp>
        <setSpec>blackwellopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="tjp15095" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Physiol</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Physiol</journal-id>
              <journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id>
              <journal-id journal-id-type="publisher-id">TJP</journal-id>
              <journal-id journal-id-type="hwp">jphysiol</journal-id>
              <journal-title-group>
                <journal-title>The Journal of Physiology</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0022-3751</issn>
              <issn pub-type="epub">1469-7793</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9288513</article-id>
              <article-id pub-id-type="pmcid">PMC9288513</article-id>
              <article-id pub-id-type="pmc-uid">9288513</article-id>
              <article-id pub-id-type="pmid">35575293</article-id>
              <article-id pub-id-type="pmid">35575293</article-id>
              <article-id pub-id-type="doi">10.1113/JP282730</article-id>
              <article-id pub-id-type="publisher-id">TJP15095</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Cardiovascular</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Rho‐kinase inhibition improves haemodynamic responses and circulating ATP during hypoxia and moderate intensity handgrip exercise in healthy older adults</article-title>
                <alt-title alt-title-type="left-running-head">M. L. Racine and others</alt-title>
                <alt-title alt-title-type="right-running-head">Effects of Rho‐kinase inhibition on haemodynamics and circulating ATP</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="tjp15095-cr-0001" contrib-type="author">
                  <name>
                    <surname>Racine</surname>
                    <given-names>Matthew L.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8377-3556</contrib-id>
                  <xref rid="tjp15095-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="bio" rid="d96e47">*</xref>
                </contrib>
                <contrib id="tjp15095-cr-0002" contrib-type="author">
                  <name>
                    <surname>Terwoord</surname>
                    <given-names>Janée D.</given-names>
                  </name>
                  <xref rid="tjp15095-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="tjp15095-cr-0003" contrib-type="author">
                  <name>
                    <surname>Ketelhut</surname>
                    <given-names>Nathaniel B.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7034-4237</contrib-id>
                  <xref rid="tjp15095-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="tjp15095-cr-0004" contrib-type="author">
                  <name>
                    <surname>Bachman</surname>
                    <given-names>Nate P.</given-names>
                  </name>
                  <xref rid="tjp15095-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="tjp15095-cr-0005" contrib-type="author">
                  <name>
                    <surname>Richards</surname>
                    <given-names>Jennifer C.</given-names>
                  </name>
                  <xref rid="tjp15095-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="tjp15095-cr-0006" contrib-type="author">
                  <name>
                    <surname>Luckasen</surname>
                    <given-names>Gary J.</given-names>
                  </name>
                  <xref rid="tjp15095-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="tjp15095-cr-0007" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Dinenno</surname>
                    <given-names>Frank A.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4644-3213</contrib-id>
                  <xref rid="tjp15095-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <address>
                    <email>frank.dinenno@colostate.edu</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="tjp15095-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Human Cardiovascular Physiology Laboratory</named-content>
                <named-content content-type="organisation-division">Department of Health and Exercise Science</named-content>
                <institution>Colorado State University</institution>
                <city>Fort Collins</city>
                <named-content content-type="country-part">CO</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="tjp15095-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Medical Center of the Rockies</named-content>
                <institution>University of Colorado Health</institution>
                <city>Loveland</city>
                <named-content content-type="country-part">CO</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold> F. A. Dinenno: Department of Health and Exercise Science, Colorado State University, 220 Moby‐B Complex, Fort Collins, CO 80523‐1582, USA. Email: <email>frank.dinenno@colostate.edu</email>
<break/>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>29</day>
                <month>5</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <day>15</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>29</day>
                <month>5</month>
                <year>2022</year>
              </pub-date>
              <volume>600</volume>
              <issue seq="90">14</issue>
              <issue-id pub-id-type="doi">10.1113/tjp.v600.14</issue-id>
              <fpage>3265</fpage>
              <lpage>3285</lpage>
              <history>
                <date date-type="received">
                  <day>12</day>
                  <month>12</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>09</day>
                  <month>5</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <!--Journal compilation &#x000a9; 2022 The Physiological Society.-->
                <copyright-statement content-type="article-copyright">© 2022 The Authors. <italic toggle="yes">The Journal of Physiology</italic> published by John Wiley &amp; Sons Ltd on behalf of The Physiological Society.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:TJP-600-3265.pdf"/>
              <abstract>
                <sec id="tjp15095-sec-0010">
                  <title>Abstract</title>
                  <p>Skeletal muscle haemodynamics and circulating adenosine triphosphate (ATP) responses during hypoxia and exercise are blunted in older (OA) <italic toggle="yes">vs</italic>. young (YA) adults, which may be associated with impaired red blood cell (RBC) ATP release. Rho‐kinase inhibition improves deoxygenation‐induced ATP release from OA isolated RBCs. We tested the hypothesis that Rho‐kinase inhibition (via fasudil) <italic toggle="yes">in vivo</italic> would improve local haemodynamic and ATP responses during hypoxia and exercise in OA. Healthy YA (25 ± 3 years; <italic toggle="yes">n</italic> = 12) and OA (65 ± 5 years; <italic toggle="yes">n</italic> = 13) participated in a randomized, double‐blind, placebo‐controlled, crossover study on two days (≥5 days between visits). A forearm deep venous catheter was used to administer saline/fasudil and sample venous plasma ATP ([ATP]<sub>V</sub>). Forearm vascular conductance (FVC) and [ATP]<sub>V</sub> were measured at rest, during isocapnic hypoxia (80% <mml:math id="jats-math-1" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>), and during graded rhythmic handgrip exercise that was similar between groups (5, 15 and 25% maximum voluntary contraction (MVC)). Isolated RBC ATP release was measured during normoxia/hypoxia. With saline, ΔFVC was lower (<italic toggle="yes">P</italic> &lt; 0.05) in OA <italic toggle="yes">vs</italic>. YA during hypoxia (∼60%) and during 15 and 25% MVC (∼25–30%), and these impairments were abolished with fasudil. Similarly, [ATP]<sub>V</sub> and ATP effluent responses from normoxia to hypoxia and rest to 25% MVC were lower in OA <italic toggle="yes">vs</italic>. YA and improved with fasudil (<italic toggle="yes">P</italic> &lt; 0.05). Isolated RBC ATP release during hypoxia was impaired in OA <italic toggle="yes">vs</italic>. YA (∼75%; <italic toggle="yes">P</italic> &lt; 0.05), which tended to improve with fasudil in OA (<italic toggle="yes">P</italic> = 0.082). These data suggest Rho‐kinase inhibition improves haemodynamic responses to hypoxia and moderate intensity exercise in OA, which may be due in part to improved circulating ATP.
<boxed-text position="anchor" content-type="graphic"><graphic xlink:href="TJP-600-3265-g005.jpg" position="anchor" id="jats-graphic-3"/></boxed-text>
</p>
                </sec>
                <sec id="tjp15095-sec-0020">
                  <title>Key points</title>
                  <p>
                    <list list-type="bullet" id="tjp15095-list-0001">
                      <list-item>
                        <p>Skeletal muscle blood flow responses to hypoxia and exercise are impaired with age. Blunted increases in circulating ATP, a vasodilator, in older adults may contribute to age‐related impairments in haemodynamics.</p>
                      </list-item>
                      <list-item>
                        <p>Red blood cells (RBCs) are a primary source of circulating ATP, and treating isolated RBCs with a Rho‐kinase inhibitor improves age‐related impairments in deoxygenation‐induced RBC ATP release.</p>
                      </list-item>
                      <list-item>
                        <p>In this study, treating healthy older adults systemically with the Rho‐kinase inhibitor fasudil improved blood flow and circulating ATP responses during hypoxia and moderate intensity handgrip exercise compared to young adults, and also tended to improve isolated RBC ATP release.</p>
                      </list-item>
                      <list-item>
                        <p>Improved blood flow regulation with fasudil was also associated with increased skeletal muscle oxygen delivery during hypoxia and exercise in older adults.</p>
                      </list-item>
                      <list-item>
                        <p>This is the first study to demonstrate that Rho‐kinase inhibition can significantly improve age‐related impairments in haemodynamic and circulating ATP responses to physiological stimuli, which may have therapeutic implications.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
              </abstract>
              <abstract id="tjp15095-abs-0001" abstract-type="graphical">
                <p><bold>Abstract figure legend</bold> Skeletal muscle haemodynamics and circulating ATP responses during hypoxia and exercise are blunted with age, which may be associated with impaired red blood cell (RBC) ATP release. Rho‐kinase inhibition improves deoxygenation‐induced ATP release from isolated RBCs of older adults. In a randomized, double‐blind, placebo‐controlled, crossover study, Rho‐kinase inhibition via intravenous fasudil improved forearm haemodynamic and circulating ATP responses to systemic isocapnic hypoxia and moderate intensity rhythmic handgrip exercise in healthy older compared to young adults.
<boxed-text position="anchor" content-type="graphic"><graphic xlink:href="TJP-600-3265-g005.jpg" position="anchor" id="jats-graphic-5"/></boxed-text>
</p>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="tjp15095-kwd-0001">ageing</kwd>
                <kwd id="tjp15095-kwd-0002">ATP</kwd>
                <kwd id="tjp15095-kwd-0003">blood flow</kwd>
                <kwd id="tjp15095-kwd-0004">exercise</kwd>
                <kwd id="tjp15095-kwd-0005">fasudil</kwd>
                <kwd id="tjp15095-kwd-0006">hypoxia</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institutes of Health
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>HL119337</award-id>
                  <award-id>F31HL126377</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="8"/>
                <table-count count="4"/>
                <page-count count="21"/>
                <word-count count="12955"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>15 July 2022</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.0 mode:remove_FC converted:07.10.2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <fn-group>
                <fn id="tjp15095-note-0001">
                  <p>Edited by: Michael Hogan &amp; Bruno Grassi</p>
                </fn>
                <fn id="tjp15095-note-0002">
                  <p>Linked articles: This article is highlighted in a Perspective article by González‐Alonso. To read this article, visit <ext-link xlink:href="https://doi.org/10.1113/JP283322" ext-link-type="uri">https://doi.org/10.1113/JP283322</ext-link>.</p>
                </fn>
                <fn id="tjp15095-note-0003">
                  <p>The peer review history is available in the <xref rid="tjp15095-supitem-0002" ref-type="supplementary-material">Supporting information</xref> section of this article (<ext-link xlink:href="https://doi.org/10.1113/JP282730#support-information-section" ext-link-type="uri">https://doi.org/10.1113/JP282730#support‐information‐section</ext-link>).</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body>
            <sec id="tjp15095-sec-0030">
              <title>Introduction</title>
              <p>Cardiovascular disease (CVD) remains the leading cause of death worldwide and the majority of CVD‐related mortality is associated with arterial dysfunction (Benjamin et al., <xref rid="tjp15095-bib-0003" ref-type="bibr">2017</xref>). Advancing age is the primary risk factor for CVD, and over 90% of all deaths associated with CVD are estimated to occur in adults over 60 years old (Benjamin et al., <xref rid="tjp15095-bib-0003" ref-type="bibr">2017</xref>). Furthermore, healthy (primary) ageing is associated with a decline in functional capacity that leads to reductions in exercise tolerance, functional independence and overall quality of life (WHO, <xref rid="tjp15095-bib-0082" ref-type="bibr">1993</xref>). All of these age‐associated changes, as well as vascular pathologies like atherosclerosis and ischaemic disease, involve impairments in vascular control and the subsequent regulation of tissue blood flow and oxygen delivery.</p>
              <p>The multifaceted nature of local blood flow regulation requires an integrated and coordinated balance between vasodilatory factors which can arise from the vascular endothelium, circulating elements in the blood, tissue metabolites, mechanical forces, and vasoconstricting signals from the sympathetic nervous system and vasculature (Clifford &amp; Hellsten, <xref rid="tjp15095-bib-0011" ref-type="bibr">2004</xref>; Hellsten et al., <xref rid="tjp15095-bib-0033" ref-type="bibr">2012</xref>; Laughlin et al., <xref rid="tjp15095-bib-0045" ref-type="bibr">2012</xref>; Mortensen &amp; Saltin, <xref rid="tjp15095-bib-0051" ref-type="bibr">2014</xref>; Segal, <xref rid="tjp15095-bib-0065" ref-type="bibr">2005</xref>). Primary ageing is associated with increases in sympathetic nervous system activity (reviewed by Dinenno &amp; Joyner, <xref rid="tjp15095-bib-0021" ref-type="bibr">2006</xref>) and declines in the production or bioavailability of vasodilatory molecules, as well as reductions in skeletal muscle blood flow during physiological stimuli such as exercise (for review, see Hearon Jr. &amp; Dinenno, <xref rid="tjp15095-bib-0031" ref-type="bibr">2016</xref>; Proctor &amp; Parker, <xref rid="tjp15095-bib-0053" ref-type="bibr">2006</xref>; Wray &amp; Richardson, <xref rid="tjp15095-bib-0086" ref-type="bibr">2015</xref>) and hypoxia (Casey et al., <xref rid="tjp15095-bib-0009" ref-type="bibr">2011</xref>; Richards et al., <xref rid="tjp15095-bib-0057" ref-type="bibr">2017</xref>). Of these alterations in vasoactive stimuli, attenuated local vasodilatory signalling is likely to be a major contributor to the age‐related impairment in blood flow regulation, as data from our laboratory suggest that augmented sympathetic vasoconstriction does not contribute to the reduction in peripheral vasodilatation and skeletal muscle hyperaemia during hypoxia or handgrip exercise in older adults (Richards et al., <xref rid="tjp15095-bib-0057" ref-type="bibr">2017</xref>, <xref rid="tjp15095-bib-0058" ref-type="bibr">2014</xref>).</p>
              <p>Among the vasodilatory signals affected by ageing, blunted increases in circulating adenosine triphosphate (ATP) during hypoxia and exercise (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>) may be one of the most significant impairments given the unique ability of circulating ATP to stimulate local and conducted vasodilatation via binding to purinergic P<sub>2Y</sub> receptors on the endothelium (Collins et al., <xref rid="tjp15095-bib-0012" ref-type="bibr">1998</xref>; Dora, <xref rid="tjp15095-bib-0023" ref-type="bibr">2017</xref>; Winter &amp; Dora, <xref rid="tjp15095-bib-0085" ref-type="bibr">2007</xref>) while also blunting sympathetic α‐adrenergic vasoconstriction (Hearon Jr. et al., <xref rid="tjp15095-bib-0032" ref-type="bibr">2017</xref>; Kirby et al., <xref rid="tjp15095-bib-0044" ref-type="bibr">2008</xref>; Rosenmeier et al., <xref rid="tjp15095-bib-0062" ref-type="bibr">2004</xref>). Importantly, it has been demonstrated that the vasodilatory responsiveness to exogenous ATP is preserved in the forearm of older adults (Kirby et al., <xref rid="tjp15095-bib-0041" ref-type="bibr">2010</xref>), and although this may differ in other vascular beds (e.g. the leg) dependent on physical activity status (Mortensen et al., <xref rid="tjp15095-bib-0050" ref-type="bibr">2012</xref>), the collective evidence suggests that potential age‐related impairments in the contribution of ATP to vascular control and regulation of skeletal muscle blood flow are related to the source of intravascular ATP.</p>
              <p>In this context, red blood cells (RBCs) release ATP in response to cell deformation and in direct proportion to the degree of haemoglobin deoxygenation, and can therefore contribute to the coupling of blood flow and oxygen delivery to tissue metabolic demand (Bergfeld &amp; Forrester, <xref rid="tjp15095-bib-0004" ref-type="bibr">1992</xref>; Dietrich et al., <xref rid="tjp15095-bib-0018" ref-type="bibr">2000</xref>; Ellsworth, <xref rid="tjp15095-bib-0024" ref-type="bibr">2000</xref>; Ellsworth &amp; Sprague, <xref rid="tjp15095-bib-0026" ref-type="bibr">2012</xref>; Ellsworth et al., <xref rid="tjp15095-bib-0025" ref-type="bibr">1995</xref>; González‐Alonso et al., <xref rid="tjp15095-bib-0028" ref-type="bibr">2002</xref>; Jagger et al., <xref rid="tjp15095-bib-0035" ref-type="bibr">2001</xref>; Jensen, <xref rid="tjp15095-bib-0036" ref-type="bibr">2009</xref>; Sprague et al., <xref rid="tjp15095-bib-0074" ref-type="bibr">2009</xref>). Furthermore, increases in circulating ATP during exercise are dependent on intact skeletal muscle perfusion (i.e. intravascular sources), further implicating the RBC as a primary source of intravascular ATP (Kirby et al., <xref rid="tjp15095-bib-0040" ref-type="bibr">2013</xref>). We recently demonstrated that increases in plasma ATP during hypoxia and exercise are impaired with advancing age, and this is likely due to impaired deoxygenation‐induced ATP release from isolated RBCs of older adults (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>). We also recently demonstrated that reduced RBC deformability in older adults is a primary underlying mechanism of impaired deoxygenation‐induced ATP release and that improving deformability via treatment of isolated RBCs from healthy older adults with a Rho‐kinase inhibitor can restore their ability to release ATP in response to deoxygenation (Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>). However, whether Rho‐kinase inhibition improves ATP release <italic toggle="yes">in vivo</italic> and haemodynamic responses to hypoxia and exercise in healthy older adults is unknown. Thus, the primary goal of the present study was to test the hypothesis that systemic administration of the Rho‐kinase inhibitor fasudil would improve the haemodynamic responses to hypoxia and exercise in healthy older adults and that this would be accompanied by improvements in circulating ATP and deoxygenation‐induced ATP release from isolated RBCs. We chose the forearm model to test our hypotheses given our prior findings of impaired forearm haemodynamic and plasma ATP responses during rhythmic handgrip exercise and systemic hypoxia in older adults (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>).</p>
            </sec>
            <sec id="tjp15095-sec-0040">
              <title>Methods</title>
              <sec id="tjp15095-sec-0050">
                <title>Ethical approval and subjects</title>
                <p>With approval from the Institutional Review Board at Colorado State University (protocol 16‐6361H) and after written informed consent, a total of 12 young and 13 older healthy adults participated in the present investigation. All subjects were free from overt cardiovascular disease as assessed from a medical history, free of cardiovascular medications, non‐smokers, non‐obese (body mass index &lt;30 kg m<sup>−2</sup>), normotensive (resting blood pressure &lt;140/90), and sedentary to moderately active. Young female subjects were studied during the early follicular phase of their menstrual cycle to minimize any potential cardiovascular effects of sex‐specific hormones, whereas older female subjects were post‐menopausal and not on hormone replacement therapy. Additionally, older subjects were further evaluated for clinical evidence of cardiopulmonary disease with a physical examination and resting and exercise (Balke protocol) electrocardiograms. Body composition was determined by whole‐body dual‐energy X‐ray absorptiometry scans (QDR series software, Hologic, Inc., Marlborough, MA, USA). Whole blood lipid panels were run using a Piccolo Xpress chemistry analyser (Abaxis, Union City, CA, USA). Studies were performed in the Human Cardiovascular Physiology Laboratory at Colorado State University (altitude: ∼1500 m) after an overnight fast, 24‐h abstention from alcohol/substance use, and a 12‐h abstention from caffeine and exercise, with subjects in the supine position with the experimental arm abducted to 90° and slightly elevated above heart level upon a tilt‐adjustable table. All studies were performed according to the <italic toggle="yes">Declaration of Helsinki</italic>.</p>
              </sec>
              <sec id="tjp15095-sec-0060">
                <title>Experimental design and general experimental protocol</title>
                <p>The overall experimental design and timeline for each experimental visit is depicted in Fig. <xref rid="tjp15095-fig-0001" ref-type="fig">1</xref>. Using a double‐blind, placebo‐controlled, crossover design, subjects were randomized to receive an infusion of either saline (placebo control) or the Rho‐kinase inhibitor fasudil for their first experimental visit. Subjects then received the opposite treatment for their second experimental visit, with at least 5 days and no more than 2 months between the first and second visit. Fasudil and hydroxyfasudil are metabolized quickly (half‐life of ∼45 min and ∼280 min, respectively, with a 60 mg 60 min<sup>−1</sup> infusion of fasudil; Shibuya et al., <xref rid="tjp15095-bib-0066" ref-type="bibr">2005</xref>) and thus typically administered two to three times per day in clinical practice (Jiang et al., <xref rid="tjp15095-bib-0037" ref-type="bibr">2015</xref>; Satoh et al., <xref rid="tjp15095-bib-0063" ref-type="bibr">2014</xref>; Shibuya et al., <xref rid="tjp15095-bib-0066" ref-type="bibr">2005</xref>, <xref rid="tjp15095-bib-0067" ref-type="bibr">1992</xref>; Suzuki et al., <xref rid="tjp15095-bib-0078" ref-type="bibr">2007</xref>, <xref rid="tjp15095-bib-0079" ref-type="bibr">2008</xref>; Zhao et al., <xref rid="tjp15095-bib-0087" ref-type="bibr">2011</xref>). Therefore, at least 5 days between visits was deemed to be sufficient for washout of any potential effects of fasudil administration.</p>
                <fig position="float" fig-type="Figure" id="tjp15095-fig-0001">
                  <label>Figure 1</label>
                  <caption>
                    <title>Overall experimental design and experimental visit timeline</title>
                    <p><italic toggle="yes">A</italic>, double‐blind, placebo‐controlled, randomized, crossover experimental design. After screening, eligible subjects were randomized in a double‐blind manner to receive an infusion of either saline (placebo control) or fasudil for their first experimental visit. Subjects then received the opposite treatment for their second experimental visit, with at least 5 days between visits. <italic toggle="yes">B</italic>, experimental visit timeline. After placement of the venous catheter and treatment infusion, experimental measures were made during systemic isocapnic hypoxia and graded‐intensity rhythmic handgrip exercise trials; order of the trials was randomized and counterbalanced between subjects, but kept the same for both visits within a subject. Timing of blood sampling is indicated by arrows (Fig. <xref rid="tjp15095-fig-0001" ref-type="fig">1B</xref>), with samples for plasma [ATP] taken under steady‐state conditions at rest, during hypoxia and the end of each exercise workload.</p>
                  </caption>
                  <graphic xlink:href="TJP-600-3265-g003" position="anchor" id="jats-graphic-7"/>
                </fig>
                <p>All experimental measures were performed in the same order for each visit within a subject, with the order of hypoxia and graded‐intensity rhythmic handgrip exercise trials randomized and counterbalanced between subjects. For both the hypoxia and exercise trials, resting haemodynamics were measured for 2−3 min until a steady‐state was observed, after which the physiological stimulus was initiated. The hypoxia trial consisted of 3 min of steady‐state hypoxia at an oxygen saturation of ∼80% as assessed via pulse oximetry on the earlobe (<mml:math id="jats-math-2" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>; plus ∼2 min for the normoxia to hypoxia transition). The exercise trial consisted of 4 min at each workload to ensure that steady‐state haemodynamics were achieved. Timing of blood sampling is indicated by arrows (Fig. <xref rid="tjp15095-fig-0001" ref-type="fig">1<italic toggle="yes">B</italic>
</xref>), with blood samples for plasma [ATP] taken under steady‐state conditions at rest, the end of hypoxia and the end of each exercise workload.</p>
              </sec>
              <sec id="tjp15095-sec-0070">
                <title>Venous catheterization</title>
                <p>As described previously by our laboratory (Crecelius et al., <xref rid="tjp15095-bib-0014" ref-type="bibr">2013</xref>, <xref rid="tjp15095-bib-0016" ref-type="bibr">2011</xref>; Kirby et al., <xref rid="tjp15095-bib-0040" ref-type="bibr">2013</xref>, <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Racine et al., <xref rid="tjp15095-bib-0054" ref-type="bibr">2018</xref>), an 18‐ or 20‐gauge (depending on inspection of vein size) 5.1 cm catheter was inserted in retrograde fashion into an antecubital vein of the experimental arm for treatment administration and deep venous blood samples. The catheter was connected to a three‐way stopcock, with one connection to an intravenous solution set for treatment administration followed by continuous flushing with saline at a rate of ∼2 ml min<sup>−1</sup> for the duration of the study to keep it patent and the other connection to a 10‐ or 3‐ml syringe for blood sampling. Sample size variability in some blood draw‐dependent measures (e.g. ATP and blood gases) is due to loss of catheter patency in some participants.</p>
              </sec>
              <sec id="tjp15095-sec-0080">
                <title>Intravenous fasudil and placebo (saline) administration</title>
                <p>Fasudil monohydrochloride (fasudil; LC Laboratories, Woburn, MA, USA) was prepared in saline (10 mg ml<sup>−1</sup> sodium chloride 0.9% PF injection; Pencol Compounding Pharmacy, Denver, CO, USA) and passed all measures for purity by HPLC, sterility, endotoxins and fungal presence (Analytical Research Laboratories, Oklahoma City, OK, USA) prior to use. Sixty milligrams of fasudil (6 ml vial) was added to a 100 ml saline bag immediately prior to administration, covered to protect it from exposure to light, and infused intravenously over 60 min (Shibuya et al., <xref rid="tjp15095-bib-0066" ref-type="bibr">2005</xref>). This single dose of fasudil was well‐tolerated by both young and older adults, and no adverse events were observed or reported in either age group. For the placebo control visit, administration of saline was identical to that of fasudil, with a covered 100 ml saline bag infused intravenously over 60 min. Fasudil mixed in saline was indistinguishable from saline alone, and thus all investigators and subjects remained blinded during treatment administration.</p>
              </sec>
              <sec id="tjp15095-sec-0090">
                <title>Forearm blood flow and vascular conductance</title>
                <p>A 12 MHz linear‐array ultrasound probe (Vivid 7, GE Healthcare, Milwaukee, WI, USA) was used to determine brachial artery mean blood velocity (MBV) and diameter proximal to the catheter insertion site as described previously (Crecelius et al., <xref rid="tjp15095-bib-0016" ref-type="bibr">2011</xref>; Hearon Jr. et al., <xref rid="tjp15095-bib-0032" ref-type="bibr">2017</xref>; Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Racine et al., <xref rid="tjp15095-bib-0054" ref-type="bibr">2018</xref>; Richards et al., <xref rid="tjp15095-bib-0057" ref-type="bibr">2017</xref>). Foam tape was used to mark the outline of the probe for consistent placement and measurement over the course of the experiments. For blood velocity measurements, the probe insonation angle was maintained at &lt;60° and the frequency used was 5 MHz. The Doppler shift frequency spectrum was analysed via a Multigon 500 M TCD (Multigon Industries, Mt Vernon, NY, USA) spectral analyser from which MBV was determined as a weighted mean of the spectrum of Doppler shift frequencies. Brachial artery diameter measurements were made in duplex mode at end‐diastole and between contractions (at least in triplicate) during steady‐state conditions (Crecelius et al., <xref rid="tjp15095-bib-0016" ref-type="bibr">2011</xref>; Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Racine et al., <xref rid="tjp15095-bib-0054" ref-type="bibr">2018</xref>; Richards et al., <xref rid="tjp15095-bib-0057" ref-type="bibr">2017</xref>). Forearm blood flow (FBF) was calculated as: FBF = MBV × π × (brachial artery diameter/2)<sup>2</sup> × 60, where FBF is expressed in ml min<sup>−1</sup>, MBV in cm s<sup>−1</sup>, brachial diameter in cm, and 60 was used to convert from ml s<sup>−1</sup> to ml min<sup>−1</sup>. Forearm vascular conductance (FVC) was calculated as (FBF MAP<sup>−1</sup>) × 100 and expressed in ml min<sup>−1</sup> 100 mmHg<sup>−1</sup> (Hearon Jr. et al., <xref rid="tjp15095-bib-0032" ref-type="bibr">2017</xref>; Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Racine et al., <xref rid="tjp15095-bib-0054" ref-type="bibr">2018</xref>; Richards et al., <xref rid="tjp15095-bib-0057" ref-type="bibr">2017</xref>, <xref rid="tjp15095-bib-0058" ref-type="bibr">2014</xref>). Haemodynamic data are presented as absolute values as well as the response from baseline (Δ) to take into account individual differences in baseline FBF and FVC. All studies were performed in a semi‐darkened, cool (20–22°C), temperature‐controlled environment with a fan directed toward the forearm to minimize the contribution of skin blood flow to forearm haemodynamics.</p>
              </sec>
              <sec id="tjp15095-sec-0100">
                <title>Systemic isocapnic hypoxia</title>
                <p>The systemic isocapnic hypoxia trial was performed using a self‐regulating partial rebreathe system developed by Banzett et al. (<xref rid="tjp15095-bib-0001" ref-type="bibr">2000</xref>) and more recently described by our laboratory (Crecelius et al., <xref rid="tjp15095-bib-0016" ref-type="bibr">2011</xref>; Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Markwald et al., <xref rid="tjp15095-bib-0048" ref-type="bibr">2011</xref>; Racine et al., <xref rid="tjp15095-bib-0054" ref-type="bibr">2018</xref>; Richards et al., <xref rid="tjp15095-bib-0057" ref-type="bibr">2017</xref>). This system allows for constant alveolar fresh air ventilation independent of changes in breathing frequency or tidal volume (Banzett et al., <xref rid="tjp15095-bib-0001" ref-type="bibr">2000</xref>; Dinenno et al., <xref rid="tjp15095-bib-0022" ref-type="bibr">2003</xref>; Wilkins et al., <xref rid="tjp15095-bib-0084" ref-type="bibr">2008</xref>). Using this system, we were able to clamp end‐tidal CO<sub>2</sub> levels despite the hypoxia‐induced increases in ventilation. The level of oxygen was manipulated by mixing nitrogen with medical air via an anaesthesia gas blender. Specifically, inspired oxygen was titrated to achieve an <mml:math id="jats-math-3" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> of ∼80%. Subjects breathed through a scuba mouthpiece with a nose‐clip to prevent nasal breathing. An anaesthesia monitor (Cardiocap/5, Datex‐Ohmeda, Louisville, CO, USA) was used to determine heart rate (HR; 3‐lead ECG) and expired CO<sub>2</sub> sampled at the mouthpiece. Ventilation was measured via a turbine pneumotachograph (model 17125 UVM, Vacu‐Med, Ventura, CA, USA).</p>
              </sec>
              <sec id="tjp15095-sec-0110">
                <title>Graded‐intensity rhythmic handgrip exercise</title>
                <p>Maximum voluntary contraction (MVC) was determined for the experimental arm as the average of three maximal squeezes of a handgrip dynamometer (Stoelting, Chicago, IL, USA) that were within 3% of each other. Rhythmic handgrip exercise during the trials was performed with weights corresponding to 5%, 15% and 25% MVC (∼15%, 40% and 70% of maximal work rate, respectively; Richards et al., <xref rid="tjp15095-bib-0058" ref-type="bibr">2014</xref>) attached to a pulley system and lifted 4−5 cm over the pulley at a duty cycle of 1 s contraction−2 s relaxation (20 contractions per min) using both visual and auditory feedback to ensure the correct timing (Dinenno &amp; Joyner, <xref rid="tjp15095-bib-0019" ref-type="bibr">2003</xref>, <xref rid="tjp15095-bib-0020" ref-type="bibr">2004</xref>; Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Richards et al., <xref rid="tjp15095-bib-0058" ref-type="bibr">2014</xref>). Handgrip exercise was performed for 4 min at each workload, for a total of 12 min.</p>
              </sec>
              <sec id="tjp15095-sec-0120">
                <title>Blood sampling and measurement of [fasudil], [hydroxyfasudil], plasma [ATP], plasma [Hb] and blood gases</title>
                <p>Timing of deep venous blood samples is indicated by arrows in Fig. <xref rid="tjp15095-fig-0001" ref-type="fig">1</xref>. Based on preliminary pharmacokinetics experiments performed in our laboratory (data not shown), a blood sample for peak plasma concentrations of fasudil and hydroxyfasudil was taken ∼15 min after the treatment infusion ended and an additional sample was taken at the end of the study immediately prior to catheter removal to confirm that concentrations of each compound remained at a level that can effectively inhibit Rho‐kinase, which has been shown to range from 0.08 to 1.9 μ<sc>m</sc> for fasudil (Davies et al., <xref rid="tjp15095-bib-0017" ref-type="bibr">2000</xref>; Jacobs et al., <xref rid="tjp15095-bib-0034" ref-type="bibr">2006</xref>; Rikitake et al., <xref rid="tjp15095-bib-0061" ref-type="bibr">2005</xref>; Satoh et al., <xref rid="tjp15095-bib-0064" ref-type="bibr">2012</xref>; Shibuya et al., <xref rid="tjp15095-bib-0066" ref-type="bibr">2005</xref>; Wickman et al., <xref rid="tjp15095-bib-0083" ref-type="bibr">2003</xref>) and from 0.04 to 1.8 μM for hydroxyfasudil (Jacobs et al., <xref rid="tjp15095-bib-0034" ref-type="bibr">2006</xref>; Rikitake et al., <xref rid="tjp15095-bib-0061" ref-type="bibr">2005</xref>; Satoh et al., <xref rid="tjp15095-bib-0064" ref-type="bibr">2012</xref>; Shibuya et al., <xref rid="tjp15095-bib-0066" ref-type="bibr">2005</xref>; Shimokawa, <xref rid="tjp15095-bib-0068" ref-type="bibr">2002</xref>; Shimokawa et al., <xref rid="tjp15095-bib-0069" ref-type="bibr">1999</xref>).</p>
                <p>The plasma concentrations of fasudil and hydroxyfasudil were measured by the Colorado State University Analytical Resources Core using triple quadrupole UPLC‐MS/MS as described by Chen et al. (<xref rid="tjp15095-bib-0010" ref-type="bibr">2010</xref>). Briefly, stock solutions of standard fasudil (1 mg ml<sup>−1</sup>), hydroxyfasudil (0.5 mg ml<sup>−1</sup>) and ranitidine (1 mg ml<sup>−1</sup>) were prepared in methanol. A nine‐point calibration curve was prepared with fasudil and hydroxyfasudil using ranitidine as an internal standard in methanol, and in a pooled blank plasma created by mixing aliquots of plasma from test subjects following saline injection. Analytical samples and matrix calibration solutions were prepared by mixing a 230 μl aliquot of plasma, 400 μl methanol and 70 μl of a 5 μg ml<sup>−1</sup> solution of ranitidine in an Eppendorf tube; they were vortexed for 30 s, and centrifuged at 11,000 rpm for 5 min; 150 μl of the supernatant was transferred to an autosampler vial. Quality control samples and blanks were run every eight injections and all injections were introduced in duplicate. Data were processed using the response ratio for target analytes fasudil and hydroxyfasudil to the internal standard ranitidine.</p>
                <p>Blood samples for plasma [ATP] and blood gases were taken immediately after the treatment infusion (ATP standard curve sample) and at the end of rest, hypoxia and each exercise intensity. Our method for blood sampling, preparation and measurement of plasma [ATP] (Crecelius et al., <xref rid="tjp15095-bib-0014" ref-type="bibr">2013</xref>; Kirby et al., <xref rid="tjp15095-bib-0040" ref-type="bibr">2013</xref>, <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>) generally follows the procedures established by Gorman and colleagues (Gorman et al., <xref rid="tjp15095-bib-0029" ref-type="bibr">2007</xref>, <xref rid="tjp15095-bib-0030" ref-type="bibr">2003</xref>) and was performed as previously described in detail (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>). Briefly, ∼3–5 ml of venous blood was drawn directly into a pre‐heparinized 10 ml syringe, from which 2 ml was gently and at once expelled into a tube containing 2.7 ml of an ATP‐stabilizing solution to equal a blood:diluent ratio of 1.35 (Crecelius et al., <xref rid="tjp15095-bib-0014" ref-type="bibr">2013</xref>; Gorman et al., <xref rid="tjp15095-bib-0029" ref-type="bibr">2007</xref>, <xref rid="tjp15095-bib-0030" ref-type="bibr">2003</xref>; Kirby et al., <xref rid="tjp15095-bib-0040" ref-type="bibr">2013</xref>, <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>). This ATP‐stabilizing solution is used to inhibit the degradation of ATP via nucleotidases and additional ATP release post‐sampling. The blood‐diluent mixture was immediately centrifuged at ∼1200 <italic toggle="yes">g</italic> (4000 rpm) for 3 min at 22°C, and 100 μl of the supernatant was taken for measurement of plasma [ATP] via luciferin‐luciferase assay. An ATP standard curve was created on each visit prior to hypoxia and exercise trials using plasma from each subject studied as the medium. All plasma ATP measures were performed at least in triplicate.</p>
                <p>To account for the potential influence of RBC haemolysis on measures of plasma [ATP], which can increase significantly with only small amounts of haemolysis, a 1 ml sample of plasma supernatant from the blood–diluent mixture was taken immediately following ATP measurements and analysed for plasma haemoglobin (Hb) via spectrophotometry (SpectraMax, Molecular Devices, Sunnyvale, CA, USA) at wavelengths of 415, 380 and 450 nm as described previously by our laboratory (Crecelius et al., <xref rid="tjp15095-bib-0014" ref-type="bibr">2013</xref>; Kirby et al., <xref rid="tjp15095-bib-0040" ref-type="bibr">2013</xref>, <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>). The percentage haemolysis was then calculated as [(100 – haematocrit) × plasma [Hb] total [Hb]<sup>−1</sup>] × 100. Any sample that was more than 2 standard deviations from the mean percentage haemolysis was excluded from the analysis and regarded as a technical error.</p>
                <p>Blood gas samples (∼2 ml) were immediately (&lt;1 min) analysed with a clinical blood gas analyser (Rapid Point 400 Series Automatic Blood Gas System, Siemens Healthcare Diagnostics, Deerfield, IL, USA) for partial pressures of oxygen and carbon dioxide (<mml:math id="jats-math-4" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math> and <mml:math id="jats-math-5" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">C</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>), pH, fraction of oxygenated haemoglobin (<mml:math id="jats-math-6" display="inline"><mml:mrow><mml:msub><mml:msub><mml:mi>F</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub><mml:mi>Hb</mml:mi></mml:msub></mml:mrow></mml:math>), oxygen content and Hb.</p>
              </sec>
              <sec id="tjp15095-sec-0130">
                <title>RBC isolation and deoxygenation</title>
                <p>Blood was collected from the antecubital vein catheter into two Vacutainer tubes containing sodium heparin (158 USP units). Whole blood was centrifuged (500 <italic toggle="yes">g</italic>, 4°C, 10 min) followed by removal of the plasma and buffy coat by aspiration. All RBC ATP measures were performed immediately after RBC isolation was completed. RBCs were diluted to 20% haematocrit with a bicarbonate‐based buffer containing (in mM): 4.7 KCl, 2.0 CaCl<sub>2</sub>, 1.2 MgSO<sub>4</sub>, 140.5 NaCl, 11.1 glucose, 23.8 NaHCO<sub>3</sub>, and 0.5% BSA warmed to 37°C. As described previously by our laboratory (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>), these 20% haematocrit RBC suspensions were placed in a rotating bulb tonometer (Eschweiler GmbH &amp; Co. KG, Germany) and incubated for 30 min in normoxia (16% O<sub>2</sub>, 6% CO<sub>2</sub>, balance nitrogen; <mml:math id="jats-math-7" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math> ∼123 mmHg and <mml:math id="jats-math-8" display="inline"><mml:mrow><mml:msub><mml:msub><mml:mi>F</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub><mml:mi>Hb</mml:mi></mml:msub></mml:mrow></mml:math> ∼95% across all age groups and conditions) at 37°C. RBC samples were removed from the tonometer bulb for measurement of extracellular and intracellular ATP in normoxia (details below). RBCs were then deoxygenated by exposure to hypoxia (1.5% O<sub>2</sub>, 6% CO<sub>2</sub>, balanced nitrogen; <mml:math id="jats-math-9" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math> ∼25 mmHg and <mml:math id="jats-math-10" display="inline"><mml:mrow><mml:msub><mml:msub><mml:mi>F</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub><mml:mi>Hb</mml:mi></mml:msub></mml:mrow></mml:math> ∼34% across all age groups and conditions) for 15 min, the goal of which was to reduce <mml:math id="jats-math-11" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math> and <mml:math id="jats-math-12" display="inline"><mml:mrow><mml:msub><mml:msub><mml:mi>F</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub><mml:mi>Hb</mml:mi></mml:msub></mml:mrow></mml:math> to levels within the range observed <italic toggle="yes">in vivo</italic> during conditions such as exercise (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>), and RBC samples were taken for measurement of ATP as in normoxia. Normoxic and hypoxic gases were blended with a gas blender (MCQ Gas Blender Series 100, Rome, Italy) and humidified before introduction into the tonometer bulbs. Blood gases were confirmed by blood gas analysis (Siemens Rapid Point 405 Series Automatic Blood Gas System, Los Angeles, CA, USA) (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>).</p>
              </sec>
              <sec id="tjp15095-sec-0140">
                <title>Measurements of extracellular ATP and RBC total intracellular ATP</title>
                <p>ATP was measured by the luciferin–luciferase technique as described previously (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>; Richards et al., <xref rid="tjp15095-bib-0060" ref-type="bibr">2013</xref>; Sprague et al., <xref rid="tjp15095-bib-0073" ref-type="bibr">2001</xref>; Sridharan, Adderley et al., <xref rid="tjp15095-bib-0075" ref-type="bibr">2010</xref>; Sridharan, Sprague et al., <xref rid="tjp15095-bib-0076" ref-type="bibr">2010</xref>; Thuet et al., <xref rid="tjp15095-bib-0080" ref-type="bibr">2011</xref>), with light emission during the reaction detected by a luminometer (TD 20/20, Turner Designs, Sunnyvale, CA, USA). For measurement of extracellular ATP (i.e. ATP release), a 10 μl sample of the 20% haematocrit suspension was taken from the tonometer bulb and diluted 500‐fold (0.04% haematocrit), from which a 200 μl sample was taken and injected into a cuvette containing 100 μl of firefly tail extract (10 mg ml<sup>−1</sup> deionized water; Sigma‐Aldrich, St Louis, MO, USA) and 100 μl of <sc>d</sc>‐luciferin (0.5 mg ml<sup>−1</sup> deionized water; Research Products International, Mount Prospect, IL, USA). Peak light output was measured at least in triplicate for each experimental condition and the mean was used for determination of ATP levels by comparison to a standard curve for ATP (Calbiochem, San Diego, CA, USA) generated on the day of the experiment. Cell counts were obtained from each 0.04% RBC suspension and extracellular ATP was normalized to 4 × 10<sup>8</sup> cells. To confirm that ATP release was not due to haemolysis, the 0.04% RBC suspensions from which samples for ATP analysis and cell counting were taken were analysed for free haemoglobin by measuring absorbance at 405 nm similar to previous reports (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>, <xref rid="tjp15095-bib-0043" ref-type="bibr">2014</xref>; Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>; Richards et al., <xref rid="tjp15095-bib-0060" ref-type="bibr">2013</xref>; Sprague et al., <xref rid="tjp15095-bib-0071" ref-type="bibr">2011</xref>, <xref rid="tjp15095-bib-0072" ref-type="bibr">1998</xref>; Sridharan, Adderley et al., <xref rid="tjp15095-bib-0075" ref-type="bibr">2010</xref>; Thuet et al., <xref rid="tjp15095-bib-0080" ref-type="bibr">2011</xref>) as well as at 570 nm and subtracting out the background at 700 nm as recently suggested by Keller and colleagues (Keller et al., <xref rid="tjp15095-bib-0038" ref-type="bibr">2017</xref>), and samples with significant lysis were excluded, which occurred in less than 1% of samples (Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>).</p>
                <p>To determine if donor age or <italic toggle="yes">in vivo</italic> fasudil administration affected total intracellular ATP or the increase in RBC glycolytic activity during hypoxia (Campanella et al., <xref rid="tjp15095-bib-0007" ref-type="bibr">2005</xref>; Kirby et al., <xref rid="tjp15095-bib-0043" ref-type="bibr">2014</xref>; Lewis et al., <xref rid="tjp15095-bib-0046" ref-type="bibr">2009</xref>; Messana et al., <xref rid="tjp15095-bib-0049" ref-type="bibr">1996</xref>; Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>), 50 μl samples of the 20% haematocrit RBC suspension were taken from the tonometer bulb in normoxia and hypoxia following measurement of extracellular ATP and lysed in deionized water at room temperature (a 20‐fold dilution). This lysate was diluted an additional 400‐fold (8000‐fold total) and ATP was measured by the same approach used for determination of extracellular ATP (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>, <xref rid="tjp15095-bib-0043" ref-type="bibr">2014</xref>; Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>; Sprague et al., <xref rid="tjp15095-bib-0071" ref-type="bibr">2011</xref>; Sridharan, Adderley et al., <xref rid="tjp15095-bib-0075" ref-type="bibr">2010</xref>; Sridharan, Sprague et al., <xref rid="tjp15095-bib-0076" ref-type="bibr">2010</xref>; Thuet et al., <xref rid="tjp15095-bib-0080" ref-type="bibr">2011</xref>). Values were normalized to ATP concentration per RBC.</p>
              </sec>
              <sec id="tjp15095-sec-0150">
                <title>Data acquisition and analysis</title>
                <p>All <italic toggle="yes">in vivo</italic> data were collected and stored on a computer at 250 Hz and were analysed offline with signal‐processing software (WinDaq, DATAQ Instruments, Akron, OH, USA). Resting MAP was determined non‐invasively over the brachial artery (Cardiocap/5). Beat‐by‐beat MAP was measured at the heart level by finger photoplethysmography (Finometer, FMS, Amsterdam, Netherlands) on the middle finger of the control hand during hypoxia and rhythmic handgrip exercise trials (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>). FBF, HR, MAP, and oxygen saturations (pulse oximetry) represent an average of the last 30 s of the appropriate time period. Minute ventilation and end‐tidal CO<sub>2</sub> in the hypoxia trial were determined from an average of the data over the last minute of each time period in order to ensure an adequate number of sampling points.</p>
                <p>Oxygen delivery, extraction, and consumption were quantified using venous oxygen content (<mml:math id="jats-math-13" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">v</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>) determined from deep venous blood samples taken at the end of rest, hypoxia, and each exercise intensity along with estimates of arterial oxygen content (<mml:math id="jats-math-14" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>) calculated as previously published by our laboratory (Richards et al., <xref rid="tjp15095-bib-0059" ref-type="bibr">2018</xref>): <mml:math id="jats-math-15" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> = (Hb × 1.36 × <mml:math id="jats-math-16" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>) + <mml:math id="jats-math-17" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> × 0.003, where <mml:math id="jats-math-18" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> was measured via pulse oximetry and <mml:math id="jats-math-19" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> during normoxia (at rest in hypoxia trial and throughout the duration of the exercise trial) and hypoxia (80% <mml:math id="jats-math-20" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>) was estimated based on previously published arterial blood gas data in young and older adults in our laboratory (Richards et al., <xref rid="tjp15095-bib-0057" ref-type="bibr">2017</xref>). Importantly, several studies including those from our laboratory have shown that arterial oxygen content does not change during forearm (handgrip) exercise in humans (Casey et al., <xref rid="tjp15095-bib-0008" ref-type="bibr">2010</xref>; Crecelius et al., <xref rid="tjp15095-bib-0016" ref-type="bibr">2011</xref>). Arteriovenous oxygen difference was calculated as <mml:math id="jats-math-21" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> – <mml:math id="jats-math-22" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">v</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>. Oxygen delivery was calculated as <mml:math id="jats-math-23" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> × FBF × 0.001 and expressed in ml min<sup>−1</sup>. Oxygen extraction, reported as a percentage, was calculated as (<mml:math id="jats-math-24" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> – <mml:math id="jats-math-25" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">v</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>) <mml:math id="jats-math-26" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>
<sup>−1</sup> × 100. Oxygen consumption across the forearm (<mml:math id="jats-math-27" display="inline"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math>) was calculated as (<mml:math id="jats-math-28" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> – <mml:math id="jats-math-29" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">v</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>) × FBF × 0.001 and expressed in ml min<sup>−1</sup>.</p>
                <p>To account for changes in FBF and its impact on [ATP] concentration measurements and to quantify the rate of total ATP draining the active muscle, ATP effluent was calculated as FBF × [ATP] × 0.001, as quantified previously by our laboratory (Crecelius et al., <xref rid="tjp15095-bib-0014" ref-type="bibr">2013</xref>; Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>) and similar to other methods of data quantification when blood flow is altered (Giannarelli et al., <xref rid="tjp15095-bib-0027" ref-type="bibr">2009</xref>; González‐Alonso et al., <xref rid="tjp15095-bib-0028" ref-type="bibr">2002</xref>).</p>
              </sec>
              <sec id="tjp15095-sec-0160">
                <title>Statistics</title>
                <p>All values are reported as means ± SD. All analyses were performed using R (R Core Team 2016, R Foundation for Statistical Computing, Vienna, Austria) with the lme4, lmerTest, pbkrtest and lsmeans packages. Age (young or older), drug (saline or fasudil), condition (rest or exercise intensity or hypoxia), and age × drug × condition for three‐way repeated measures or age × drug for two‐way repeated measures ANOVA were treated as fixed effects. In order to account for the crossover design, subject and subject × drug were included in the model as random effects for the three‐way repeated measures analyses and subject was included as a random effect for the two‐way repeated measures analyses. When an interaction or main effect was found, appropriate pairwise comparisons were made and a Tukey test was included when necessary. Comparisons of variables relative to zero were tested using a one‐tailed Student's <italic toggle="yes">t</italic>‐test, and differences in subject characteristics were tested using a two‐tailed <italic toggle="yes">t</italic>‐test. Comparisons between saline and fasudil were performed within age group and comparisons between young and old were performed within condition. Significance was set at <italic toggle="yes">P</italic> &lt; 0.05.</p>
              </sec>
            </sec>
            <sec id="tjp15095-sec-0170">
              <title>Results</title>
              <sec id="tjp15095-sec-0180">
                <title>Subject characteristics and plasma [fasudil] and [hydroxyfasudil]</title>
                <p>Subject characteristics are reported in Table <xref rid="tjp15095-tbl-0001" ref-type="table">1</xref>. The mean age difference between the young and older adults was 40 years. Older adults had a significantly higher body fat percentage compared to young adults (<italic toggle="yes">P</italic> = 0.009), but all other characteristics were similar, including forearm fat‐free mass (<italic toggle="yes">P</italic> = 0.952), MVC (<italic toggle="yes">P</italic> = 0.461) and all exercise workloads (<italic toggle="yes">P</italic> = 0.463–0.563). In a subset of subjects (<italic toggle="yes">n</italic> = 14; seven young and seven older adults), blood samples were taken approximately 15 min after the treatment infusion stopped (peak) and at the end of the study just before the venous catheter was removed (end) for measurement of plasma concentrations of fasudil and hydroxyfasudil. The average [fasudil] at peak and end was 1.003 ± 1.199 and 0.071 ± 0.038 μM, respectively, and the average [hydroxyfasudil] at peak and end was 2.208 ± 0.709 and 1.013 ± 0.499 μM, respectively. Importantly, there were no differences between young and older adults, and fasudil was well‐tolerated in all subjects with no adverse events.</p>
                <table-wrap position="float" id="tjp15095-tbl-0001" content-type="Table">
                  <label>Table 1</label>
                  <caption>
                    <p>Subject characteristics</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">Young</th>
                        <th align="center" rowspan="1" colspan="1">Older</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Male:female</td>
                        <td align="center" rowspan="1" colspan="1">6:6</td>
                        <td align="center" rowspan="1" colspan="1">6:7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age (years)</td>
                        <td align="char" rowspan="1" colspan="1">25 ± 3</td>
                        <td align="char" rowspan="1" colspan="1">65 ± 5<xref rid="tjp15095-tbl1-note-0001" ref-type="table-fn"><sup>*</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Body mass index (kg m<sup>−2</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">23.1 ± 2.2</td>
                        <td align="char" rowspan="1" colspan="1">25.2 ± 3.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Body fat (%)</td>
                        <td align="char" rowspan="1" colspan="1">24.5 ± 7.2</td>
                        <td align="char" rowspan="1" colspan="1">33.6 ± 8.5<xref rid="tjp15095-tbl1-note-0001" ref-type="table-fn"><sup>*</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Forearm volume (ml)</td>
                        <td align="char" rowspan="1" colspan="1">879.6 ± 255.3</td>
                        <td align="char" rowspan="1" colspan="1">1002.1 ± 339.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Forearm fat‐free mass (g)</td>
                        <td align="char" rowspan="1" colspan="1">733.7 ± 287.3</td>
                        <td align="char" rowspan="1" colspan="1">726.7 ± 293.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Maximum voluntary contraction (kg)</td>
                        <td align="char" rowspan="1" colspan="1">33 ± 11</td>
                        <td align="char" rowspan="1" colspan="1">29 ± 10</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">5% workload (kg)</td>
                        <td align="char" rowspan="1" colspan="1">1.6 ± 0.5</td>
                        <td align="char" rowspan="1" colspan="1">1.5 ± 0.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">15% workload (kg)</td>
                        <td align="char" rowspan="1" colspan="1">4.9 ± 1.7</td>
                        <td align="char" rowspan="1" colspan="1">4.4 ± 1.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">25% workload (kg)</td>
                        <td align="char" rowspan="1" colspan="1">8.1 ± 2.7</td>
                        <td align="char" rowspan="1" colspan="1">7.4 ± 2.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Total cholesterol (mg dl<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">153 ± 31</td>
                        <td align="char" rowspan="1" colspan="1">182 ± 41</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">LDL cholesterol (mg dl<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">83 ± 22</td>
                        <td align="char" rowspan="1" colspan="1">106 ± 32</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HDL cholesterol (mg dl<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">53 ± 12</td>
                        <td align="char" rowspan="1" colspan="1">59 ± 13</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">LDL:HDL</td>
                        <td align="char" rowspan="1" colspan="1">1.6 ± 0.4</td>
                        <td align="char" rowspan="1" colspan="1">1.8 ± 0.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Triglycerides (mg dl<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">83 ± 28</td>
                        <td align="char" rowspan="1" colspan="1">89 ± 29</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tjp15095-tbl1-note-0001">
                      <label>*</label>
                      <p><italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. young (within condition).</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="tjp15095-sec-0190">
                <title>Effects of age and fasudil on ventilation, haemodynamics and plasma ATP during systemic isocapnic hypoxia</title>
                <p>Haemodynamics and ventilatory parameters during normoxia and systemic isocapnic hypoxia are reported in Table <xref rid="tjp15095-tbl-0002" ref-type="table">2</xref>. <mml:math id="jats-math-30" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>, minute ventilation and end‐tidal CO<sub>2</sub> were not significantly different between age groups in the saline condition, and while there were small age‐group differences in <mml:math id="jats-math-31" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> and minute ventilation in the fasudil condition, ∼80% <mml:math id="jats-math-32" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> was achieved in both conditions and age groups. MAP was significantly higher in older <italic toggle="yes">vs</italic>. young adults during normoxia and hypoxia with saline. Fasudil significantly reduced MAP in older adults and abolished the age‐group differences during normoxia and hypoxia (<italic toggle="yes">P</italic> = 0.004 and 0.008; Table <xref rid="tjp15095-tbl-0002" ref-type="table">2</xref>). There were no differences in baseline (normoxia) FBF or FVC between age groups or treatment conditions (Fig. <xref rid="tjp15095-fig-0002" ref-type="fig">2<italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>
</xref>). The increase in FBF and FVC from normoxia to hypoxia was lower in older <italic toggle="yes">vs</italic>. young adults in the saline control condition (ΔFBF 2.1 ± 2.1 <italic toggle="yes">vs</italic>. 6.3 ± 3.9 ml min<sup>−1</sup> and ΔFVC 2.8 ± 3.3 <italic toggle="yes">vs</italic>. 7.1 ± 4.6 ml min<sup>−1</sup> 100 mmHg<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.031 and 0.028). Fasudil significantly improved FBF and FVC responses to hypoxia in older adults only, such that there was no longer a difference between older and young adults (ΔFBF 8.4 ± 6.9 <italic toggle="yes">vs</italic>. 6.2 ± 4.0 ml min<sup>−1</sup> and ΔFVC 9.0 ± 6.3 <italic toggle="yes">vs</italic>. 6.2 ± 3.6 ml min<sup>−1</sup> 100 mmHg<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.250 and 0.147) (Fig. <xref rid="tjp15095-fig-0002" ref-type="fig">2<italic toggle="yes">C</italic> and <italic toggle="yes">D</italic>
</xref>).</p>
                <table-wrap position="float" id="tjp15095-tbl-0002" content-type="Table">
                  <label>Table 2</label>
                  <caption>
                    <p>Haemodynamics and ventilatory parameters during systemic hypoxia</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Young</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Older</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">Normoxia</th>
                        <th align="center" rowspan="1" colspan="1">Hypoxia</th>
                        <th align="center" rowspan="1" colspan="1">Normoxia</th>
                        <th align="center" rowspan="1" colspan="1">Hypoxia</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Saline</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">MAP (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">88 ± 7</td>
                        <td align="char" rowspan="1" colspan="1">89 ± 6</td>
                        <td align="char" rowspan="1" colspan="1">99 ± 10<xref rid="tjp15095-tbl2-note-0003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">98 ± 14<xref rid="tjp15095-tbl2-note-0003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">HR (beats min<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">57 ± 7</td>
                        <td align="char" rowspan="1" colspan="1">78 ± 12</td>
                        <td align="char" rowspan="1" colspan="1">59 ± 7</td>
                        <td align="char" rowspan="1" colspan="1">68 ± 8<xref rid="tjp15095-tbl2-note-0003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1"><mml:math id="jats-math-33" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">v</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">28.1 ± 5.3</td>
                        <td align="char" rowspan="1" colspan="1">26.6 ± 2.1</td>
                        <td align="char" rowspan="1" colspan="1">26.7 ± 4.8</td>
                        <td align="char" rowspan="1" colspan="1">25.8 ± 4.5</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1"><mml:math id="jats-math-34" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>vC</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">43.8 ± 3.1</td>
                        <td align="char" rowspan="1" colspan="1">41.8 ± 2.4</td>
                        <td align="char" rowspan="1" colspan="1">45.2 ± 3.3</td>
                        <td align="char" rowspan="1" colspan="1">43.4 ± 3.3</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">a‐vO<sub>2</sub> (ml l<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">106.5 ± 26.3</td>
                        <td align="char" rowspan="1" colspan="1">74.4 ± 12.8<xref rid="tjp15095-tbl2-note-0004" ref-type="table-fn"><sup>‡</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">103.7 ± 23.0</td>
                        <td align="char" rowspan="1" colspan="1">75.6 ± 22.1<xref rid="tjp15095-tbl2-note-0004" ref-type="table-fn"><sup>‡</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">[Hb]<sub>V</sub> (g dl<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">15.0 ± 1.0</td>
                        <td align="char" rowspan="1" colspan="1">15.1 ± 0.9</td>
                        <td align="char" rowspan="1" colspan="1">14.3 ± 1.0</td>
                        <td align="char" rowspan="1" colspan="1">14.1 ± 1.0</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1"><mml:math id="jats-math-35" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (%)</td>
                        <td align="char" rowspan="1" colspan="1">98.6 ± 1.1</td>
                        <td align="char" rowspan="1" colspan="1">79.1 ± 3.3</td>
                        <td align="char" rowspan="1" colspan="1">97.7 ± 1.5</td>
                        <td align="char" rowspan="1" colspan="1">79.7 ± 2.2</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Minute ventilation (l min<sup>−1</sup>; BTPS)</td>
                        <td align="char" rowspan="1" colspan="1">8.5 ± 2.2</td>
                        <td align="char" rowspan="1" colspan="1">16.6 ± 3.3</td>
                        <td align="char" rowspan="1" colspan="1">8.5 ± 3.4</td>
                        <td align="char" rowspan="1" colspan="1">14.4 ± 3.1</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">End‐tidal CO<sub>2</sub> (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">40.7 ± 2.8</td>
                        <td align="char" rowspan="1" colspan="1">39.9 ± 2.9</td>
                        <td align="char" rowspan="1" colspan="1">38.3 ± 4.0</td>
                        <td align="char" rowspan="1" colspan="1">37.6 ± 3.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Fasudil</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">MAP (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">87 ± 8</td>
                        <td align="char" rowspan="1" colspan="1">90 ± 12</td>
                        <td align="char" rowspan="1" colspan="1">92 ± 9<xref rid="tjp15095-tbl2-note-0002" ref-type="table-fn"><sup>*</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">92 ± 10<xref rid="tjp15095-tbl2-note-0002" ref-type="table-fn"><sup>*</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">HR (beats min<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">59 ± 10</td>
                        <td align="char" rowspan="1" colspan="1">79 ± 11</td>
                        <td align="char" rowspan="1" colspan="1">57 ± 6</td>
                        <td align="char" rowspan="1" colspan="1">67 ± 10<xref rid="tjp15095-tbl2-note-0003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1"><mml:math id="jats-math-36" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">v</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">31.6 ± 6.6</td>
                        <td align="char" rowspan="1" colspan="1">25.1 ± 2.3</td>
                        <td align="char" rowspan="1" colspan="1">28.8 ± 3.0</td>
                        <td align="char" rowspan="1" colspan="1">26.3 ± 4.8</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1"><mml:math id="jats-math-37" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>vC</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">43.0 ± 5.5</td>
                        <td align="char" rowspan="1" colspan="1">43.2 ± 4.2</td>
                        <td align="char" rowspan="1" colspan="1">46.1 ± 3.8</td>
                        <td align="char" rowspan="1" colspan="1">42.5 ± 3.8<xref rid="tjp15095-tbl2-note-0004" ref-type="table-fn"><sup>‡</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">a‐vO<sub>2</sub> (ml l<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">92.4 ± 34.7</td>
                        <td align="char" rowspan="1" colspan="1">70.2 ± 16.5</td>
                        <td align="char" rowspan="1" colspan="1">91.3 ± 12.9</td>
                        <td align="char" rowspan="1" colspan="1">66.7 ± 20.8<xref rid="tjp15095-tbl2-note-0004" ref-type="table-fn"><sup>‡</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">[Hb]<sub>V</sub> (g dl<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">14.8 ± 1.4</td>
                        <td align="char" rowspan="1" colspan="1">14.7 ± 1.3</td>
                        <td align="char" rowspan="1" colspan="1">14.0 ± 0.8</td>
                        <td align="char" rowspan="1" colspan="1">13.6 ± 0.9</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1"><mml:math id="jats-math-38" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (%)</td>
                        <td align="char" rowspan="1" colspan="1">98.7 ± 1.5</td>
                        <td align="char" rowspan="1" colspan="1">77.5 ± 3.4</td>
                        <td align="char" rowspan="1" colspan="1">97.3 ± 2.0</td>
                        <td align="char" rowspan="1" colspan="1">79.6 ± 2.5<xref rid="tjp15095-tbl2-note-0003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Minute ventilation (l min<sup>−1</sup>; BTPS)</td>
                        <td align="char" rowspan="1" colspan="1">8.9 ± 2.8</td>
                        <td align="char" rowspan="1" colspan="1">19.0 ± 5.0<xref rid="tjp15095-tbl2-note-0002" ref-type="table-fn"><sup>*</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">9.0 ± 4.0</td>
                        <td align="char" rowspan="1" colspan="1">13.7 ± 3.7<xref rid="tjp15095-tbl2-note-0003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">End‐tidal CO<sub>2</sub> (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">39.6 ± 3.5</td>
                        <td align="char" rowspan="1" colspan="1">38.8 ± 3.1</td>
                        <td align="char" rowspan="1" colspan="1">37.3 ± 5.7</td>
                        <td align="char" rowspan="1" colspan="1">37.2 ± 3.9</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tjp15095-tbl2-note-0001">
                      <p><italic toggle="yes">n</italic> = 11 for young (6M/5F).</p>
                    </fn>
                    <fn id="tjp15095-tbl2-note-0002">
                      <label>*</label>
                      <p><italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. saline.</p>
                    </fn>
                    <fn id="tjp15095-tbl2-note-0003">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p><italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. young (within condition).</p>
                    </fn>
                    <fn id="tjp15095-tbl2-note-0004">
                      <label>
                        <sup>‡</sup>
                      </label>
                      <p><italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. normoxia (blood gases only).</p>
                    </fn>
                    <fn id="tjp15095-tbl2-note-0005">
                      <p>Abbreviations: a‐vO<sub>2</sub>, arteriovenous oxygen difference; BTPS, body temperature and pressure (saturated); [Hb]<sub>V</sub>, venous haemoglobin concentration; HR, heart rate; MAP, mean arterial pressure; <mml:math id="jats-math-39" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>vC</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>, venous partial pressure of carbon dioxide; <mml:math id="jats-math-40" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">v</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>, venous partial pressure of oxygen; <mml:math id="jats-math-41" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>, peripheral oxygen saturation.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
                <fig position="float" fig-type="Figure" id="tjp15095-fig-0002">
                  <label>Figure 2</label>
                  <caption>
                    <title>Effects of age and fasudil on forearm haemodynamics and plasma ATP during systemic hypoxia</title>
                    <p><italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>, fasudil significantly increased absolute forearm blood flow (FBF) and vascular conductance (FVC) in older adults during hypoxia; differences between age groups were not significant. <italic toggle="yes">C</italic> and <italic toggle="yes">D</italic>, age‐related impairments in ΔFBF and ΔFVC responses from normoxia to hypoxia were reversed with fasudil. <italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>, venous plasma ATP ([ATP]<sub>V</sub>) and ATP effluent increased <italic toggle="yes">vs</italic>. normoxia in older adults with fasudil, but not saline; differences between age groups were not significant. <sup>*</sup>
<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. saline; †<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. young; ‡<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. normoxia.</p>
                  </caption>
                  <graphic xlink:href="TJP-600-3265-g001" position="anchor" id="jats-graphic-9"/>
                </fig>
                <p>Resting venous plasma [ATP] and ATP effluent in normoxia were not different between older and young adults in saline (90.3 ± 54.4 <italic toggle="yes">vs</italic>. 79.9 ± 48.3 nmol l<sup>−1</sup> and 1.9 ± 1.2 <italic toggle="yes">vs</italic>. 1.6 ± 1.2 nmol min<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.679 and 0.604) or fasudil (71.5 ± 37.4 <italic toggle="yes">vs</italic>. 81.3 ± 50.3 nmol l<sup>−1</sup> and 1.7 ± 1.0 <italic toggle="yes">vs</italic>. 1.5 ± 0.8 nmol min<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.695 and 0.763) conditions, and within each age group these values were not different between saline and fasudil (<italic toggle="yes">P</italic> = 0.346–0.951) (Fig. <xref rid="tjp15095-fig-0002" ref-type="fig">2<italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>
</xref>). In older adults, [ATP]<sub>V</sub> and ATP effluent during hypoxia did not significantly increase <italic toggle="yes">vs</italic>. normoxia with saline (95.7 ± 67.8 <italic toggle="yes">vs</italic>. 90.3 ± 54.4 nmol l<sup>−1</sup> and 2.2 ± 1.4 <italic toggle="yes">vs</italic>. 1.9 ± 1.2 nmol min<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.574 and 0.251), whereas with fasudil the increase during hypoxia <italic toggle="yes">vs</italic>. normoxia tended to be higher for [ATP]<sub>V</sub> (88.8 ± 74.1 <italic toggle="yes">vs</italic>. 71.5 ± 37.4 nmol l<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.073) and was significantly higher for ATP effluent (2.9 ± 2.1 <italic toggle="yes">vs</italic>. 1.7 ± 1.0 nmol min<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> &lt; 0.0001) (Fig. <xref rid="tjp15095-fig-0002" ref-type="fig">2<italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>
</xref>). In young adults, [ATP]<sub>V</sub> increased from normoxia to hypoxia with saline but not fasudil, whereas ATP effluent increased in both conditions (Fig. <xref rid="tjp15095-fig-0002" ref-type="fig">2<italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>
</xref>). Sample size variability between haemodynamics and plasma ATP measures is due to loss of catheter patency in some participants.</p>
              </sec>
              <sec id="tjp15095-sec-0200">
                <title>Effects of age and fasudil on haemodynamics and plasma ATP during graded‐intensity rhythmic handgrip exercise</title>
                <p>Haemodynamics and blood gases at baseline and during graded‐intensity rhythmic handgrip exercise are reported in Table <xref rid="tjp15095-tbl-0003" ref-type="table">3</xref>. MAP was significantly higher in older <italic toggle="yes">vs</italic>. young adults at all time points with saline (<italic toggle="yes">P</italic> = 0.001–0.034), but was significantly reduced with fasudil in the older adults such that there was no longer an age‐related difference (Table <xref rid="tjp15095-tbl-0003" ref-type="table">3</xref>; <italic toggle="yes">P</italic> = 0.005–0.038). Resting FBF and FVC were unaffected by age or fasudil (Fig. <xref rid="tjp15095-fig-0003" ref-type="fig">3<italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>
</xref>; <italic toggle="yes">P</italic> = 0.807–0.908 and 0.743–0.977). With saline, the FVC response from rest to exercise was lower in older <italic toggle="yes">vs</italic>. young adults at 15% and 25% MVC (ΔFVC 142.0 ± 52.2 <italic toggle="yes">vs</italic>. 187.8 ± 59.0 ml min<sup>−1</sup> 100 mmHg<sup>−1</sup> and 228.8 ± 71.3 <italic toggle="yes">vs</italic>. 329.9 ± 87.1 ml min<sup>−1</sup> 100 mmHg<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.045 and &lt;0.0001; Fig. <xref rid="tjp15095-fig-0003" ref-type="fig">3<italic toggle="yes">B</italic> and <italic toggle="yes">D</italic>
</xref>), as was the FBF response at 25% MVC (ΔFBF 255.3 ± 71.6 <italic toggle="yes">vs</italic>. 315.4 ± 107.3 ml min<sup>−1</sup>; <italic toggle="yes">P</italic> = 0.023; Fig. <xref rid="tjp15095-fig-0003" ref-type="fig">3<italic toggle="yes">A</italic> and <italic toggle="yes">C</italic>
</xref>). When absolute haemodynamics are normalized to workload to account for possible individual differences between young and older participants, no significant differences were observed in FBF at any exercise intensity whereas FVC was significantly lower in older adults at 25% MVC (35.9 ± 12.2 <italic toggle="yes">vs</italic>. 45.7 ± 9.6 ml min<sup>−1</sup> 100 mmHg<sup>−1</sup> kg<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.038). Fasudil significantly improved the FBF and FVC responses to exercise in older adults at 25% MVC <italic toggle="yes">vs</italic>. saline (ΔFBF 304.2 ± 90.9 <italic toggle="yes">vs</italic>. 255.3 ± 71.6 ml min<sup>−1</sup> and ΔFVC 289.6 ± 74.5 <italic toggle="yes">vs</italic>. 228.8 ± 71.3 ml min<sup>−1</sup> 100 mmHg<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.001 and &lt;0.0001). In contrast, fasudil blunted the FBF and FVC responses in young adults at 25% MVC <italic toggle="yes">vs</italic>. saline (ΔFBF 283.0 ± 87.8 <italic toggle="yes">vs</italic>. 315.4 ± 107.3 ml min<sup>−1</sup> and ΔFVC: 283.5 ± 70.3 <italic toggle="yes">vs</italic>. 329.9 ± 87.1 ml min<sup>−1</sup> 100 mmHg<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.038 and 0.002), and thus there was no longer an age‐related impairment in haemodynamics (Fig. <xref rid="tjp15095-fig-0003" ref-type="fig">3<italic toggle="yes">A</italic>–<italic toggle="yes">D</italic>
</xref>).</p>
                <table-wrap position="float" id="tjp15095-tbl-0003" content-type="Table">
                  <label>Table 3</label>
                  <caption>
                    <p>Haemodynamics and blood gases during graded‐intensity rhythmic handgrip exercise</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="center" colspan="4" style="border-bottom:solid 1px #000000" rowspan="1">Young</th>
                        <th align="center" colspan="4" style="border-bottom:solid 1px #000000" rowspan="1">Older</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">Rest</th>
                        <th align="center" rowspan="1" colspan="1">5% MVC</th>
                        <th align="center" rowspan="1" colspan="1">15% MVC</th>
                        <th align="center" rowspan="1" colspan="1">25% MVC</th>
                        <th align="center" rowspan="1" colspan="1">Rest</th>
                        <th align="center" rowspan="1" colspan="1">5% MVC</th>
                        <th align="center" rowspan="1" colspan="1">15% MVC</th>
                        <th align="center" rowspan="1" colspan="1">25% MVC</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Saline</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">MAP (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">87 ± 9</td>
                        <td align="char" rowspan="1" colspan="1">90 ± 12</td>
                        <td align="char" rowspan="1" colspan="1">90 ± 14</td>
                        <td align="char" rowspan="1" colspan="1">94 ± 18</td>
                        <td align="char" rowspan="1" colspan="1">100 ± 11<xref rid="tjp15095-tbl3-note-0002" ref-type="table-fn"><sup>†</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">102 ± 15<xref rid="tjp15095-tbl3-note-0002" ref-type="table-fn"><sup>†</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">106 ± 17<xref rid="tjp15095-tbl3-note-0002" ref-type="table-fn"><sup>†</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">112 ± 18<xref rid="tjp15095-tbl3-note-0002" ref-type="table-fn"><sup>†</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">HR (beats min<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">57 ± 9</td>
                        <td align="char" rowspan="1" colspan="1">61 ± 9</td>
                        <td align="char" rowspan="1" colspan="1">63 ± 9</td>
                        <td align="char" rowspan="1" colspan="1">67 ± 8</td>
                        <td align="char" rowspan="1" colspan="1">58 ± 8</td>
                        <td align="char" rowspan="1" colspan="1">60 ± 7</td>
                        <td align="char" rowspan="1" colspan="1">62 ± 7</td>
                        <td align="char" rowspan="1" colspan="1">63 ± 7</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1"><mml:math id="jats-math-42" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">v</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">25.7 ± 6.2</td>
                        <td align="char" rowspan="1" colspan="1">20.3 ± 2.1</td>
                        <td align="char" rowspan="1" colspan="1">24.5 ± 4.1</td>
                        <td align="char" rowspan="1" colspan="1">26.3 ± 4.4</td>
                        <td align="char" rowspan="1" colspan="1">27.3 ± 8.1</td>
                        <td align="char" rowspan="1" colspan="1">18.8 ± 3.0</td>
                        <td align="char" rowspan="1" colspan="1">22.4 ± 3.5</td>
                        <td align="char" rowspan="1" colspan="1">25.0 ± 3.5</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1"><mml:math id="jats-math-43" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>vC</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">43.3 ± 2.7</td>
                        <td align="char" rowspan="1" colspan="1">49.5 ± 3.5</td>
                        <td align="char" rowspan="1" colspan="1">51.9 ± 5.4</td>
                        <td align="char" rowspan="1" colspan="1">54.9 ± 7.1</td>
                        <td align="char" rowspan="1" colspan="1">43.5 ± 5.5</td>
                        <td align="char" rowspan="1" colspan="1">48.8 ± 4.8</td>
                        <td align="char" rowspan="1" colspan="1">53.9 ± 6.8</td>
                        <td align="char" rowspan="1" colspan="1">54.4 ± 6.8</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">a‐vO<sub>2</sub> (ml l<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">117.1 ± 27.2</td>
                        <td align="char" rowspan="1" colspan="1">142.2 ± 11.1</td>
                        <td align="char" rowspan="1" colspan="1">132.5 ± 15.2</td>
                        <td align="char" rowspan="1" colspan="1">126.0 ± 19.0</td>
                        <td align="char" rowspan="1" colspan="1">107.0 ± 30.5</td>
                        <td align="char" rowspan="1" colspan="1">139.7 ± 17.4</td>
                        <td align="char" rowspan="1" colspan="1">132.3 ± 20.7</td>
                        <td align="char" rowspan="1" colspan="1">121.5 ± 21.0</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">[Hb]<sub>V</sub> (g dl<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">14.8 ± 1.0</td>
                        <td align="char" rowspan="1" colspan="1">14.6 ± 1.0</td>
                        <td align="char" rowspan="1" colspan="1">14.9 ± 1.1</td>
                        <td align="char" rowspan="1" colspan="1">15.0 ± 1.1</td>
                        <td align="char" rowspan="1" colspan="1">14.4 ± 1.1</td>
                        <td align="char" rowspan="1" colspan="1">14.2 ± 1.1</td>
                        <td align="char" rowspan="1" colspan="1">14.4 ± 1.1</td>
                        <td align="char" rowspan="1" colspan="1">14.4 ± 0.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Fasudil</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">MAP (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">86 ± 9</td>
                        <td align="char" rowspan="1" colspan="1">89 ± 9</td>
                        <td align="char" rowspan="1" colspan="1">92 ± 9</td>
                        <td align="char" rowspan="1" colspan="1">98 ± 14</td>
                        <td align="char" rowspan="1" colspan="1">93 ± 11<xref rid="tjp15095-tbl3-note-0001" ref-type="table-fn">*</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">96 ± 12<xref rid="tjp15095-tbl3-note-0001" ref-type="table-fn"><sup>*</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">99 ± 12<xref rid="tjp15095-tbl3-note-0001" ref-type="table-fn"><sup>*</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">104 ± 15<xref rid="tjp15095-tbl3-note-0001" ref-type="table-fn"><sup>*</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">HR (beats min<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">56 ± 9</td>
                        <td align="char" rowspan="1" colspan="1">63 ± 8</td>
                        <td align="char" rowspan="1" colspan="1">64 ± 9</td>
                        <td align="char" rowspan="1" colspan="1">70 ± 16</td>
                        <td align="char" rowspan="1" colspan="1">55 ± 6</td>
                        <td align="char" rowspan="1" colspan="1">58 ± 7</td>
                        <td align="char" rowspan="1" colspan="1">60 ± 7</td>
                        <td align="char" rowspan="1" colspan="1">63 ± 10</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1"><mml:math id="jats-math-44" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">v</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">31.2 ± 8.9<xref rid="tjp15095-tbl3-note-0001" ref-type="table-fn"><sup>*</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">22.0 ± 4.4</td>
                        <td align="char" rowspan="1" colspan="1">22.5 ± 4.0</td>
                        <td align="char" rowspan="1" colspan="1">25.5 ± 4.4</td>
                        <td align="char" rowspan="1" colspan="1">27.3 ± 4.0</td>
                        <td align="char" rowspan="1" colspan="1">19.9 ± 4.7</td>
                        <td align="char" rowspan="1" colspan="1">21.7 ± 3.0</td>
                        <td align="char" rowspan="1" colspan="1">26.2 ± 5.1</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1"><mml:math id="jats-math-45" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>vC</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (mmHg)</td>
                        <td align="char" rowspan="1" colspan="1">43.6 ± 4.4</td>
                        <td align="char" rowspan="1" colspan="1">46.6 ± 4.0</td>
                        <td align="char" rowspan="1" colspan="1">52.9 ± 6.2</td>
                        <td align="char" rowspan="1" colspan="1">56.3 ± 9.2</td>
                        <td align="char" rowspan="1" colspan="1">44.6 ± 4.7</td>
                        <td align="char" rowspan="1" colspan="1">47.9 ± 5.6</td>
                        <td align="char" rowspan="1" colspan="1">52.4 ± 7.9</td>
                        <td align="char" rowspan="1" colspan="1">51.6 ± 8.4</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">a‐vO<sub>2</sub> (ml l<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">90.5 ± 35.2<xref rid="tjp15095-tbl3-note-0001" ref-type="table-fn"><sup>*</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">128.6 ± 15.9</td>
                        <td align="char" rowspan="1" colspan="1">134.0 ± 13.7</td>
                        <td align="char" rowspan="1" colspan="1">128.3 ± 15.8</td>
                        <td align="char" rowspan="1" colspan="1">98.8 ± 20.4</td>
                        <td align="char" rowspan="1" colspan="1">131.5 ± 23.6</td>
                        <td align="char" rowspan="1" colspan="1">126.8 ± 16.4</td>
                        <td align="char" rowspan="1" colspan="1">110.1 ± 24.3</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">[Hb]<sub>V</sub> (g dl<sup>−1</sup>)</td>
                        <td align="char" rowspan="1" colspan="1">14.5 ± 1.3</td>
                        <td align="char" rowspan="1" colspan="1">14.4 ± 1.4</td>
                        <td align="char" rowspan="1" colspan="1">14.5 ± 1.4</td>
                        <td align="char" rowspan="1" colspan="1">14.7 ± 1.4</td>
                        <td align="char" rowspan="1" colspan="1">14.1 ± 1.0</td>
                        <td align="char" rowspan="1" colspan="1">13.9 ± 1.1</td>
                        <td align="char" rowspan="1" colspan="1">14.0 ± 1.1</td>
                        <td align="char" rowspan="1" colspan="1">14.0 ± 0.7</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tjp15095-tbl3-note-0001">
                      <label>*</label>
                      <p><italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. saline.</p>
                    </fn>
                    <fn id="tjp15095-tbl3-note-0002">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p><italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. young (within condition).</p>
                    </fn>
                    <fn id="tjp15095-tbl3-note-0003">
                      <p>Abbreviations: a‐vO<sub>2</sub>, arteriovenous oxygen difference; [Hb]<sub>V</sub>, venous haemoglobin concentration; HR, heart rate; MAP, mean arterial pressure; <mml:math id="jats-math-46" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>vC</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>, venous partial pressure of carbon dioxide; <mml:math id="jats-math-47" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">v</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>, venous partial pressure of oxygen; <mml:math id="jats-math-48" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>, peripheral oxygen saturation.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
                <fig position="float" fig-type="Figure" id="tjp15095-fig-0003">
                  <label>Figure 3</label>
                  <caption>
                    <title>Effects of age and fasudil on forearm haemodynamics and plasma ATP during rhythmic handgrip exercise</title>
                    <p><italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>, with saline, forearm blood flow (FBF) was impaired during 25% maximum voluntary contraction (MVC) and forearm vascular conductance (FVC) was impaired during 15% and 25% MVC in older adults. Fasudil significantly increased FBF and FVC at 25% MVC in older adults and decreased FVC at 25% MVC in young adults. <italic toggle="yes">C</italic> and <italic toggle="yes">D</italic>, ΔFBF and ΔFVC responses from rest to exercise were impaired in older <italic toggle="yes">vs</italic>. young adults at 25% MVC with saline and were improved with fasudil in older adults, but not younger. <italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>, with saline, [ATP]<sub>V</sub> and ATP effluent were significantly reduced in older <italic toggle="yes">vs</italic>. young adults at 5% and 25% MVC, respectively, and improved with fasudil at these same exercise intensities in older adults, but not younger. <sup>*</sup>
<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. saline; †<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. young; ‡<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. rest ([ATP]<sub>V</sub> only).</p>
                  </caption>
                  <graphic xlink:href="TJP-600-3265-g002" position="anchor" id="jats-graphic-11"/>
                </fig>
                <p>Venous plasma [ATP] and ATP effluent at rest were not different between older and young adults in saline (53.6 ± 19.4 <italic toggle="yes">vs</italic>. 74.1 ± 41.1 nmol l<sup>−1</sup> and 1.3 ± 0.8 <italic toggle="yes">vs</italic>. 1.6 ± 1.1 nmol min<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.395 and 0.967) or fasudil (74.3 ± 46.1 <italic toggle="yes">vs</italic>. 69.5 ± 39.3 nmol l<sup>−1</sup> and 2.0 ± 1.4 <italic toggle="yes">vs</italic>. 1.7 ± 1.2 nmo min<sup>−1</sup>, respectively; <italic toggle="yes">P</italic> = 0.842 and 0.963) conditions, and within each age group these values were not different between saline and fasudil (<italic toggle="yes">P</italic> = 0.318–0.982) (Fig. <xref rid="tjp15095-fig-0003" ref-type="fig">3<italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>
</xref>). In the saline condition, plasma [ATP]<sub>V</sub> at 5% MVC was significantly lower in older vs young adults (59.3 ± 28.7 <italic toggle="yes">vs</italic>. 107.7 ± 52.3 nmol l<sup>−1</sup>; <italic toggle="yes">P</italic> = 0.048) and ATP effluent was lower at 25% MVC in older adults (23.7 ± 14.0 <italic toggle="yes">vs</italic>. 43.6 ± 31.0 nmol min<sup>−1</sup>; <italic toggle="yes">P</italic> = 0.006) (Fig. <xref rid="tjp15095-fig-0003" ref-type="fig">3<italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>
</xref>). In older adults, fasudil increased plasma [ATP]<sub>V</sub>
<italic toggle="yes">vs</italic>. saline at 5% (128.0 ± 65.1 <italic toggle="yes">vs</italic>. 59.3 ± 28.7 nmol l<sup>−1</sup>; <italic toggle="yes">P</italic> = 0.010) and 25% (120.5 ± 75.5 <italic toggle="yes">vs</italic>. 82.0 ± 38.8 nmol l<sup>−1</sup>; <italic toggle="yes">P</italic> = 0.067) MVC and significantly increased ATP effluent <italic toggle="yes">vs</italic>. saline at 25% MVC (39.3 ± 24.8 <italic toggle="yes">vs</italic>. 23.7 ± 14.0 nmol min<sup>−1</sup>; <italic toggle="yes">P</italic> = 0.005) such that there was no longer an age‐related impairment (Fig. <xref rid="tjp15095-fig-0003" ref-type="fig">3<italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>
</xref>). Sample size variability between haemodynamics and plasma ATP measures is due to loss of catheter patency in some participants.</p>
              </sec>
              <sec id="tjp15095-sec-0210">
                <title>Effects of age and fasudil on oxygen delivery and consumption during systemic isocapnic hypoxia and graded‐intensity rhythmic handgrip exercise</title>
                <p>In older adults, forearm oxygen delivery during hypoxia increased with fasudil <italic toggle="yes">vs</italic>. saline (4.3 ± 1.7 <italic toggle="yes">vs</italic>. 3.5 ± 1.3 ml min<sup>−1</sup>, <italic toggle="yes">P</italic> = 0.053) (Fig. <xref rid="tjp15095-fig-0004" ref-type="fig">4<italic toggle="yes">A</italic>
</xref>). During 25% MVC exercise, forearm oxygen delivery and <mml:math id="jats-math-49" display="inline"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math> were lower in older <italic toggle="yes">vs</italic>. young adults with saline (51.6 ± 15.2 <italic toggle="yes">vs</italic>. 69.9 ± 28.6 ml min<sup>−1</sup>, <italic toggle="yes">P</italic> = 0.005, and 32.9 ± 10.5 <italic toggle="yes">vs</italic>. 42.4 ± 15.0 ml min<sup>−1</sup>; <italic toggle="yes">P</italic> = 0.016, respectively), but not with fasudil (58.4 ± 16.8 <italic toggle="yes">vs</italic>. 63.1 ± 24.0 ml min<sup>−1</sup>, <italic toggle="yes">P</italic> = 0.540 (<italic toggle="yes">P</italic> = 0.071 <italic toggle="yes">vs</italic>. saline), and 34.8 ± 11.7 <italic toggle="yes">vs</italic>. 39.9 ± 14.1 ml min<sup>−1</sup>; <italic toggle="yes">P</italic> = 0.213, respectively) (Fig. <xref rid="tjp15095-fig-0004" ref-type="fig">4<italic toggle="yes">B</italic> and <italic toggle="yes">F</italic>
</xref>). Sample size variability between haemodynamics and blood gas measures is due to loss of catheter patency in some participants.</p>
                <fig position="float" fig-type="Figure" id="tjp15095-fig-0004">
                  <label>Figure 4</label>
                  <caption>
                    <title>Effects of age and fasudil on forearm oxygen delivery, extraction and consumption during hypoxia (<italic toggle="yes">A</italic>, <italic toggle="yes">C</italic> and <italic toggle="yes">E</italic>) and rhythmic handgrip exercise (<italic toggle="yes">B</italic>, <italic toggle="yes">D</italic> and <italic toggle="yes">F</italic>)</title>
                    <p><italic toggle="yes">A</italic>, <italic toggle="yes">C</italic> and <italic toggle="yes">E</italic>, there were no differences in forearm O<sub>2</sub> delivery (<italic toggle="yes">A</italic>), extraction (<italic toggle="yes">C</italic>), or consumption (<italic toggle="yes">E</italic>) between young and older adults. <mml:math id="jats-math-50" display="inline"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math> tended to decrease during hypoxia in older adults with saline (<italic toggle="yes">E</italic>) and O<sub>2</sub> delivery was improved with fasudil (<italic toggle="yes">A</italic>). <italic toggle="yes">B</italic>, <italic toggle="yes">D</italic> and <italic toggle="yes">F</italic>, at 25% maximum voluntary contraction (MVC), forearm O<sub>2</sub> delivery (<italic toggle="yes">B</italic>) and <mml:math id="jats-math-51" display="inline"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math> (<italic toggle="yes">F</italic>) were impaired in older <italic toggle="yes">vs</italic>. young adults with saline, which was no longer different with fasudil. <sup>*</sup>
<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. saline; †<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. young; ‡<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. normoxia.</p>
                  </caption>
                  <graphic xlink:href="TJP-600-3265-g007" position="anchor" id="jats-graphic-13"/>
                </fig>
              </sec>
              <sec id="tjp15095-sec-0220">
                <title>Effects of age and fasudil on isolated red blood cell extracellular and intracellular ATP</title>
                <p>Blood gases for isolated RBCs are shown in Table <xref rid="tjp15095-tbl-0004" ref-type="table">4</xref>. There were no age group or drug condition differences in the fraction of oxygenated haemoglobin (<mml:math id="jats-math-52" display="inline"><mml:mrow><mml:msub><mml:msub><mml:mi>F</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub><mml:mi>Hb</mml:mi></mml:msub></mml:mrow></mml:math>), an index of the stimulus for ATP release based on the linear relationship between haemoglobin oxygenation state and extracellular ATP. In contrast to young adults, extracellular ATP from RBCs of older adults was not elevated in hypoxia compared to normoxia with saline (14.1 ± 8.9 <italic toggle="yes">vs</italic>. 12.3 ± 6.11.8 nmol/4 × 10<sup>8</sup> RBCs, respectively; <italic toggle="yes">P</italic> = 0.214) whereas it was with fasudil (16.5 ± 9.3 <italic toggle="yes">vs</italic>. 11.6 ± 6.8 nmol/4 × 10<sup>8</sup> RBCs, respectively; <italic toggle="yes">P</italic> = 0.001) (Fig. <xref rid="tjp15095-fig-0005" ref-type="fig">5<italic toggle="yes">A</italic>
</xref>). The RBC extracellular ATP response from normoxia to hypoxia was significantly lower in older <italic toggle="yes">vs</italic>. young adults with saline (15.0 ± 50.5 <italic toggle="yes">vs</italic>. 92.7 ± 52.4%, respectively; <italic toggle="yes">P</italic> = 0.001) and fasudil (53.0 ± 46.6 <italic toggle="yes">vs</italic>. 105.4 ± 54.1%, respectively; <italic toggle="yes">P</italic> 0.018), although there was a trend for fasudil to improve this change in extracellular ATP in the older adults relative to saline (53.0 ± 46.6 <italic toggle="yes">vs</italic>. 15.0 ± 50.5%, respectively; <italic toggle="yes">P</italic> = 0.082) (Fig. <xref rid="tjp15095-fig-0005" ref-type="fig">5<italic toggle="yes">B</italic>
</xref>). Finally, intracellular ATP increased in hypoxia (<italic toggle="yes">P</italic> = 0.0001–0.002) and there were no differences between age groups or drug conditions (Fig. <xref rid="tjp15095-fig-0005" ref-type="fig">5<italic toggle="yes">C</italic>
</xref>).</p>
                <table-wrap position="float" id="tjp15095-tbl-0004" content-type="Table">
                  <label>Table 4</label>
                  <caption>
                    <p>Isolated red blood cell gases</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <col align="char" char="x000B1" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="char" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">pH</th>
                        <th align="center" rowspan="1" colspan="1"><mml:math id="jats-math-53" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math> (mmHg)</th>
                        <th align="center" rowspan="1" colspan="1"><mml:math id="jats-math-54" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">C</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> (mmHg)</th>
                        <th align="center" rowspan="1" colspan="1">tHb (g dl<sup>−1</sup>)</th>
                        <th align="center" rowspan="1" colspan="1"><mml:math id="jats-math-55" display="inline"><mml:mrow><mml:msub><mml:msub><mml:mi>F</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub><mml:mi>Hb</mml:mi></mml:msub></mml:mrow></mml:math> (%)</th>
                        <th align="center" rowspan="1" colspan="1"><italic toggle="yes">F</italic><sub>HHb</sub> (%)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td colspan="2" align="left" rowspan="1">Normoxia</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Young</td>
                        <td align="char" rowspan="1" colspan="1">Saline</td>
                        <td align="char" rowspan="1" colspan="1">7.42 ± 0.05</td>
                        <td align="char" rowspan="1" colspan="1">121.5 ± 7.8</td>
                        <td align="char" rowspan="1" colspan="1">33.9 ± 2.1</td>
                        <td align="char" rowspan="1" colspan="1">6.3 ± 0.4</td>
                        <td align="char" rowspan="1" colspan="1">95.5 ± 0.6</td>
                        <td align="char" rowspan="1" colspan="1">2.9 ± 0.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">Fasudil</td>
                        <td align="char" rowspan="1" colspan="1">7.44 ± 0.07</td>
                        <td align="char" rowspan="1" colspan="1">123.0 ± 12.7</td>
                        <td align="char" rowspan="1" colspan="1">33.8 ± 7.8</td>
                        <td align="char" rowspan="1" colspan="1">6.3 ± 0.5</td>
                        <td align="char" rowspan="1" colspan="1">95.8 ± 0.5</td>
                        <td align="char" rowspan="1" colspan="1">3.0 ± 0.4</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Older</td>
                        <td align="char" rowspan="1" colspan="1">Saline</td>
                        <td align="char" rowspan="1" colspan="1">7.39 ± 0.06</td>
                        <td align="char" rowspan="1" colspan="1">123.7 ± 8.0</td>
                        <td align="char" rowspan="1" colspan="1">38.1 ± 4.2</td>
                        <td align="char" rowspan="1" colspan="1">6.7 ± 0.4<xref rid="tjp15095-tbl4-note-0002" ref-type="table-fn"><sup>†</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">95.5 ± 0.4</td>
                        <td align="char" rowspan="1" colspan="1">3.0 ± 0.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">Fasudil</td>
                        <td align="char" rowspan="1" colspan="1">7.41 ± 0.03</td>
                        <td align="char" rowspan="1" colspan="1">126.4 ± 5.5</td>
                        <td align="char" rowspan="1" colspan="1">36.2 ± 1.9</td>
                        <td align="char" rowspan="1" colspan="1">6.7 ± 0.4<xref rid="tjp15095-tbl4-note-0002" ref-type="table-fn"><sup>†</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">95.7 ± 0.4</td>
                        <td align="char" rowspan="1" colspan="1">2.8 ± 0.4</td>
                      </tr>
                      <tr>
                        <td colspan="2" align="left" rowspan="1">Hypoxia</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Young</td>
                        <td align="char" rowspan="1" colspan="1">Saline</td>
                        <td align="char" rowspan="1" colspan="1">7.44 ± 0.02</td>
                        <td align="char" rowspan="1" colspan="1">22.6 ± 3.3</td>
                        <td align="char" rowspan="1" colspan="1">35.4 ± 2.4</td>
                        <td align="char" rowspan="1" colspan="1">6.3 ± 0.5</td>
                        <td align="char" rowspan="1" colspan="1">34.1 ± 9.8</td>
                        <td align="char" rowspan="1" colspan="1">62.2 ± 9.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">Fasudil</td>
                        <td align="char" rowspan="1" colspan="1">7.45 ± 0.01</td>
                        <td align="char" rowspan="1" colspan="1">21.3 ± 3.1</td>
                        <td align="char" rowspan="1" colspan="1">34.8 ± 2.2</td>
                        <td align="char" rowspan="1" colspan="1">6.3 ± 0.4</td>
                        <td align="char" rowspan="1" colspan="1">32.1 ± 9.6</td>
                        <td align="char" rowspan="1" colspan="1">64.5 ± 8.7</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Older</td>
                        <td align="char" rowspan="1" colspan="1">Saline</td>
                        <td align="char" rowspan="1" colspan="1">7.41 ± 0.04</td>
                        <td align="char" rowspan="1" colspan="1">25.5 ± 2.1</td>
                        <td align="char" rowspan="1" colspan="1">39.2 ± 2.6</td>
                        <td align="char" rowspan="1" colspan="1">6.8 ± 0.5<xref rid="tjp15095-tbl4-note-0002" ref-type="table-fn"><sup>†</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">37.9 ± 4.8</td>
                        <td align="char" rowspan="1" colspan="1">58.4 ± 4.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">Fasudil</td>
                        <td align="char" rowspan="1" colspan="1">7.41 ± 0.03</td>
                        <td align="char" rowspan="1" colspan="1">24.8 ± 3.0</td>
                        <td align="char" rowspan="1" colspan="1">40.1 ± 2.5<xref rid="tjp15095-tbl4-note-0002" ref-type="table-fn"><sup>†</sup></xref>
</td>
                        <td align="char" rowspan="1" colspan="1">6.7 ± 0.5</td>
                        <td align="char" rowspan="1" colspan="1">36.0 ± 9.9</td>
                        <td align="char" rowspan="1" colspan="1">60.5 ± 9.6</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tjp15095-tbl4-note-0001">
                      <label>*</label>
                      <p><italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. saline.</p>
                    </fn>
                    <fn id="tjp15095-tbl4-note-0002">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p><italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. young; <italic toggle="yes">n</italic> = 11 (young) and 12 (older). Abbreviations: <italic toggle="yes">F</italic>
<sub>HHb</sub>, fraction of deoxygenated haemoglobin; <mml:math id="jats-math-56" display="inline"><mml:mrow><mml:msub><mml:msub><mml:mi>F</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub><mml:mi>Hb</mml:mi></mml:msub></mml:mrow></mml:math>, fraction of oxygenated haemoglobin; <mml:math id="jats-math-57" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="normal">C</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>, partial pressure of carbon dioxide; <mml:math id="jats-math-58" display="inline"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math>, partial pressure of oxygen; tHb, total haemoglobin.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
                <fig position="float" fig-type="Figure" id="tjp15095-fig-0005">
                  <label>Figure 5</label>
                  <caption>
                    <title>Effects of donor age and <italic toggle="yes">in vivo</italic> fasudil administration on red blood cell ATP release and intracellular ATP in normoxia and hypoxia</title>
                    <p><italic toggle="yes">A</italic>, extracellular ATP (i.e. ATP release) in hypoxia only increased significantly <italic toggle="yes">vs</italic>. normoxia from RBCs of older adults with fasudil, whereas it increased from RBCs of young adults in both conditions. <italic toggle="yes">B</italic>, the mean percentage increase in extracellular ATP from normoxia to hypoxia was impaired from RBCs of older adults in the saline and fasudil conditions, but tended to improve with fasudil compared to saline in older adults (<italic toggle="yes">P</italic> = 0.08). <italic toggle="yes">C</italic>, intracellular ATP increased from normoxia to hypoxia in all conditions and there were no differences between young and older adults. <sup>*</sup>
<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. saline; †<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. young; ‡<italic toggle="yes">P</italic> &lt; 0.05 <italic toggle="yes">vs</italic>. normoxia.</p>
                  </caption>
                  <graphic xlink:href="TJP-600-3265-g006" position="anchor" id="jats-graphic-15"/>
                </fig>
              </sec>
            </sec>
            <sec id="tjp15095-sec-0230">
              <title>Discussion</title>
              <p>To the best of our knowledge, this is the first study to investigate the effects of Rho‐kinase inhibition in healthy older adult humans as a potential means to improve age‐related impairments in the control of vascular tone and skeletal muscle blood flow during the physiological stimuli of hypoxia and exercise. The primary novel findings are as follows. First, fasudil improved the blunted local vasodilatory and blood flow responses to systemic hypoxia and moderate intensity (25% MVC) rhythmic handgrip exercise in older adults. Second, the haemodynamic improvements during systemic hypoxia and exercise with fasudil were associated with increased oxygen delivery to skeletal muscle, and thus reduced <mml:math id="jats-math-59" display="inline"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math> was no longer observed with these physiological stimuli in older adults. Third, fasudil significantly lowered mean arterial blood pressure in healthy, normotensive older adults at rest, during systemic hypoxia, and during exercise such that age‐related elevations in control conditions were abolished. Fourth, improvements in haemodynamic responses with fasudil were accompanied by improvements in circulating ATP in older adults based on trends for increased venous plasma [ATP] and significantly improved ATP effluent. Finally, <italic toggle="yes">in vivo</italic> fasudil administration tended to improve the age‐related impairment in deoxygenation‐induced ATP release from isolated RBCs. These collective findings provide the first experimental evidence that systemic Rho‐kinase inhibition improves the regulation of vascular tone and skeletal muscle blood flow, along with circulating ATP responses, during the physiological stimuli of systemic hypoxia and moderate intensity handgrip exercise in healthy older adults, which may have therapeutic implications for reducing cardiovascular disease risk and increasing exercise tolerance and functional capacity in ageing populations.</p>
              <sec id="tjp15095-sec-0240">
                <title>Ageing and impaired vascular control during hypoxia and exercise</title>
                <p>The local regulation of blood flow involves the integration of multiple signalling pathways and vascular responses, the end goal of which is the matching of oxygen supply to tissue metabolic demand. Changes in these pathways with advancing age, particularly an attenuation of local vasodilatory signalling, contribute to age‐related impairments in vascular control during physiological stimuli such as hypoxia (Casey et al., <xref rid="tjp15095-bib-0009" ref-type="bibr">2011</xref>; Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Richards et al., <xref rid="tjp15095-bib-0057" ref-type="bibr">2017</xref>) and exercise (Hearon Jr. &amp; Dinenno, <xref rid="tjp15095-bib-0031" ref-type="bibr">2016</xref>; Proctor &amp; Parker, <xref rid="tjp15095-bib-0053" ref-type="bibr">2006</xref>; Wray &amp; Richardson, <xref rid="tjp15095-bib-0086" ref-type="bibr">2015</xref>). Data from the present study are consist with these prior observations and demonstrate impaired blood flow responses due to impaired control of vascular tone in older adults. RBCs may play a central role in the coupling of oxygen supply and metabolic demand through the release of ATP in direct proportion to the degree of haemoglobin deoxygenation (Bergfeld &amp; Forrester, <xref rid="tjp15095-bib-0004" ref-type="bibr">1992</xref>; Dietrich et al., <xref rid="tjp15095-bib-0018" ref-type="bibr">2000</xref>; Ellsworth, <xref rid="tjp15095-bib-0024" ref-type="bibr">2000</xref>; Ellsworth &amp; Sprague, <xref rid="tjp15095-bib-0026" ref-type="bibr">2012</xref>; Ellsworth et al., <xref rid="tjp15095-bib-0025" ref-type="bibr">1995</xref>; González‐Alonso et al., <xref rid="tjp15095-bib-0028" ref-type="bibr">2002</xref>; Jagger et al., <xref rid="tjp15095-bib-0035" ref-type="bibr">2001</xref>; Jensen, <xref rid="tjp15095-bib-0036" ref-type="bibr">2009</xref>; Sprague et al., <xref rid="tjp15095-bib-0074" ref-type="bibr">2009</xref>), and interestingly, this process is also impaired with advancing age (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>; Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>). We recently demonstrated that treatment of isolated RBCs from older adults with a rho‐kinase inhibitor <italic toggle="yes">in vitro</italic> significantly improved ATP release during haemoglobin deoxygenation (Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>), thus serving as the impetus for the present study.</p>
              </sec>
              <sec id="tjp15095-sec-0250">
                <title>Effects of Rho‐kinase inhibition on vascular control in older adults</title>
                <p>In this first study, to the best of our knowledge, of whether systemic Rho‐kinase inhibition can improve vascular and haemodynamic responses to hypoxia and exercise in young or older adults, fasudil completely reversed the age‐related impairment in hypoxic vasodilation, resulting in improved blood flow and oxygen delivery. Further, fasudil significantly improved forearm vasodilatation and hyperaemia during moderate intensity handgrip exercise, resulting in a greater oxygen delivery and forearm <mml:math id="jats-math-60" display="inline"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math> that was no longer significantly lower with age compared with control conditions. In contrast and unexpectedly, fasudil blunted forearm vasodilator and hyperaemic responses during high‐intensity exercise in the young adults, and as such, the age group differences in forearm haemodynamics and oxygen consumption were abolished. Given that we estimated <mml:math id="jats-math-61" display="inline"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math> in the present study and that blood gasses were not obtained in all subjects, caution should be taken when interpreting the findings related to forearm <mml:math id="jats-math-62" display="inline"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:math>.</p>
              </sec>
              <sec id="tjp15095-sec-0260">
                <title>Possible mechanisms of fasudil‐mediated improvements in vascular control in older adults</title>
                <p>Our laboratory has demonstrated previously that age‐related reductions in skeletal muscle blood flow during conditions of RBC deoxygenation are due to impaired local vasodilatation associated with reduced circulating ATP (Kirby et al., <xref rid="tjp15095-bib-0042" ref-type="bibr">2012</xref>), that increases in circulating ATP are dependent on skeletal muscle perfusion and thus an intravascular source (Kirby et al., <xref rid="tjp15095-bib-0040" ref-type="bibr">2013</xref>), and that impaired deoxygenation‐induced ATP release from isolated RBCs of older adults is mechanistically linked to declines in RBC deformability with advancing donor age (Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>). Importantly, we also demonstrated that improved RBC deformability with advancing donor age via Rho‐kinase inhibition acutely increases RBC ATP release (Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>). Although the design of the present study does not permit identification of the precise underlying mechanisms of fasudil‐mediated improvements in vasodilatory and blood flow responses to systemic hypoxia and moderate intensity rhythmic handgrip exercise in older adults, there were multiple significant or trending improvements in circulating ATP during these stimuli when participants were treated with fasudil compared to saline (Figs <xref rid="tjp15095-fig-0002" ref-type="fig">2<italic toggle="yes">E</italic>, <italic toggle="yes">F</italic>
</xref> and <xref rid="tjp15095-fig-0003" ref-type="fig">3<italic toggle="yes">E</italic>, <italic toggle="yes">F</italic>
</xref>) in addition to a trend for improved isolated RBC ATP release following <italic toggle="yes">in vivo</italic> drug treatment (Fig. <xref rid="tjp15095-fig-0005" ref-type="fig">5<italic toggle="yes">B</italic>
</xref>). Given the ability of ATP to stimulate both local and conducted vasodilatation (Dora, <xref rid="tjp15095-bib-0023" ref-type="bibr">2017</xref>; Winter &amp; Dora, <xref rid="tjp15095-bib-0085" ref-type="bibr">2007</xref>) and the preserved vasodilatory responsiveness to exogenous ATP in the forearm of older adults (Kirby et al., <xref rid="tjp15095-bib-0041" ref-type="bibr">2010</xref>), these data suggest that haemodynamic improvements with fasudil during conditions of RBC deoxygenation may be due at least in part to increased ATP bioavailability.</p>
                <p>Given the diverse molecular targets of Rho‐kinase <italic toggle="yes">in vivo</italic> and the systemic administration of fasudil in the present study, there are multiple pathways beyond ATP signalling that could have contributed to the fasudil‐mediated improvements in vascular control in older adults. Rho‐kinase inhibits the synthesis of nitric oxide (NO) by phosphorylating endothelial nitric oxide synthase (eNOS) at threonine 495 (Satoh et al., <xref rid="tjp15095-bib-0063" ref-type="bibr">2014</xref>; Shimokawa et al., <xref rid="tjp15095-bib-0070" ref-type="bibr">2016</xref>; Sugimoto et al., <xref rid="tjp15095-bib-0077" ref-type="bibr">2007</xref>). In healthy humans, intra‐arterial infusion of fasudil has been shown to decrease forearm vascular tone, mediated in part by improved NO bioavailability as a result of decreased inhibition of eNOS (Büssemaker et al., <xref rid="tjp15095-bib-0006" ref-type="bibr">2007</xref>). Although we did not observe an increase in resting FVC in young or older adults when treated with systemic fasudil in the present study (Figs <xref rid="tjp15095-fig-0002" ref-type="fig">2<italic toggle="yes">B</italic>
</xref> and <xref rid="tjp15095-fig-0003" ref-type="fig">3<italic toggle="yes">B</italic>
</xref>), mean arterial pressure was significantly reduced with fasudil <italic toggle="yes">vs</italic>. saline in older adults (Tables <xref rid="tjp15095-tbl-0002" ref-type="table">2</xref> and <xref rid="tjp15095-tbl-0003" ref-type="table">3</xref>). Given that heart rate was not different between study treatments (Tables <xref rid="tjp15095-tbl-0002" ref-type="table">2</xref> and <xref rid="tjp15095-tbl-0003" ref-type="table">3</xref>), this suggests that the decrease in MAP was due to a decrease in systemic vascular resistance, which could be due in part to increased systemic NO bioavailability given the contribution of NO to basal vascular tone (Vallance et al., <xref rid="tjp15095-bib-0081" ref-type="bibr">1989</xref>). If NO bioavailability was increased by fasudil in the present study, it is possible that it contributed to the improved forearm vasodilatation during systemic hypoxia (Fig. <xref rid="tjp15095-fig-0002" ref-type="fig">2</xref>; Blitzer et al., <xref rid="tjp15095-bib-0005" ref-type="bibr">1996</xref>; Casey et al., <xref rid="tjp15095-bib-0009" ref-type="bibr">2011</xref>; Crecelius et al., <xref rid="tjp15095-bib-0016" ref-type="bibr">2011</xref>; Markwald et al., <xref rid="tjp15095-bib-0048" ref-type="bibr">2011</xref>), as well as during moderate intensity rhythmic handgrip exercise (Crecelius et al., <xref rid="tjp15095-bib-0015" ref-type="bibr">2010</xref>; Kirby et al., <xref rid="tjp15095-bib-0039" ref-type="bibr">2009</xref>; Richards et al., <xref rid="tjp15095-bib-0056" ref-type="bibr">2015</xref>), in older adults.</p>
                <p>Beyond effects on vasodilatory pathways, the Rho‐kinase inhibitors fasudil and Y‐27632 have both been shown to blunt the vascular response to multiple vasoconstrictors. Specifically, fasudil can limit α‐adrenergic vasoconstriction induced by noradrenaline and abolish endothelin‐mediated vasoconstriction (Büssemaker et al., <xref rid="tjp15095-bib-0006" ref-type="bibr">2007</xref>) and Y‐27632 has been shown to cause a dose‐dependent decrease in α<sub>1</sub>‐adrenergic vasoconstriction stimulated by phenylephrine (Löhn et al., <xref rid="tjp15095-bib-0047" ref-type="bibr">2005</xref>). If some degree of inhibition of α‐adrenergic vasoconstriction occurred in the present study, it is unlikely that it contributed to the improved vascular responses in older adults given our previous observations that local adrenoceptor blockade does not improve the age‐related impairments in forearm vasodilatation during hypoxia (80% <mml:math id="jats-math-63" display="inline"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math>) or graded‐intensity rhythmic handgrip exercise (Richards et al., <xref rid="tjp15095-bib-0057" ref-type="bibr">2017</xref>, <xref rid="tjp15095-bib-0058" ref-type="bibr">2014</xref>). However, it is possible that the effect of fasudil on endothelin‐mediated constriction (Büssemaker et al., <xref rid="tjp15095-bib-0006" ref-type="bibr">2007</xref>) could have contributed in the present study given that an age‐related increase in vasoconstriction mediated by endothelin A receptors has been identified in the leg of healthy older adults both at rest and during exercise (Barrett‐O'Keefe et al., <xref rid="tjp15095-bib-0002" ref-type="bibr">2015</xref>).</p>
              </sec>
              <sec id="tjp15095-sec-0270">
                <title>Experimental limitations</title>
                <p>The primary experimental limitation of the present study is that fasudil could not be delivered specifically to RBCs and therefore systemic drug administration was necessary to attempt to inhibit Rho‐kinase in the circulating pool of RBCs. Given that Rho‐kinase is distributed widely throughout the body and has a diverse range of cellular targets, follow‐up studies will be needed to gain more definitive mechanistic insight into the fasudil‐mediated improvements in vascular control in healthy older adults. Utilizing systemic fasudil administration in combination with local brachial artery infusion of pharmacological antagonists targeting pathways that could be altered by Rho‐kinase inhibition as described above would provide insight into the mechanisms contributing to fasudil‐mediated haemodynamic improvements (Barrett‐O'Keefe et al., <xref rid="tjp15095-bib-0002" ref-type="bibr">2015</xref>; Crecelius et al., <xref rid="tjp15095-bib-0013" ref-type="bibr">2012</xref>; Racine et al., <xref rid="tjp15095-bib-0054" ref-type="bibr">2018</xref>).</p>
                <p>Another limitation relates to the inherent difficulties of <italic toggle="yes">in vivo</italic> plasma/circulating ATP measures. In this context, ATP in circulation has an extremely short half‐life (∼0.5 s; Mortensen et al., <xref rid="tjp15095-bib-0052" ref-type="bibr">2011</xref>) and we are unable to measure ATP within the microcirculation. As such, this likely contributes to the mixed/variable data as it relates to both age‐impairments and fasudil‐mediated improvements in plasma [ATP]. In this study, it was also not possible to measure RBC deformability as in our previous <italic toggle="yes">in vitro</italic> study utilizing Rho‐kinase inhibition (Racine &amp; Dinenno, <xref rid="tjp15095-bib-0055" ref-type="bibr">2019</xref>) due to time and personnel constraints. Thus, it is possible that systemic Rho‐kinase inhibition <italic toggle="yes">in vivo</italic> did not improve RBC deformability. However, it clearly improved forearm vasodilator and haemodynamic responses to hypoxia and moderate intensity handgrip exercise in older adults.</p>
                <p>A final limitation of systemic drug administration is that fasudil and its active metabolite hydroxyfasudil can have off‐target effects from Rho‐kinase, including myosin light chain kinase, protein kinase A and protein kinase C. However, the inhibitor constant (<italic toggle="yes">K</italic>
<sub>i</sub>) of fasudil is much more specific for Rho‐kinase, ranging from 0.33 to 1.9 μM (Davies et al., <xref rid="tjp15095-bib-0017" ref-type="bibr">2000</xref>; Jacobs et al., <xref rid="tjp15095-bib-0034" ref-type="bibr">2006</xref>; Rikitake et al., <xref rid="tjp15095-bib-0061" ref-type="bibr">2005</xref>; Satoh et al., <xref rid="tjp15095-bib-0064" ref-type="bibr">2012</xref>; Shibuya et al., <xref rid="tjp15095-bib-0066" ref-type="bibr">2005</xref>; Wickman et al., <xref rid="tjp15095-bib-0083" ref-type="bibr">2003</xref>) compared to 55 μM for myosin light chain kinase (Satoh et al., <xref rid="tjp15095-bib-0064" ref-type="bibr">2012</xref>), ∼10 μM on average for protein kinase A (Davies et al., <xref rid="tjp15095-bib-0017" ref-type="bibr">2000</xref>; Jacobs et al., <xref rid="tjp15095-bib-0034" ref-type="bibr">2006</xref>; Rikitake et al., <xref rid="tjp15095-bib-0061" ref-type="bibr">2005</xref>; Satoh et al., <xref rid="tjp15095-bib-0064" ref-type="bibr">2012</xref>), and ranging from 3.3 μM to over 100 μM for protein kinase C (Rikitake et al., <xref rid="tjp15095-bib-0061" ref-type="bibr">2005</xref>; Satoh et al., <xref rid="tjp15095-bib-0064" ref-type="bibr">2012</xref>). Importantly, hydroxyfasudil is an even more potent and specific inhibitor of Rho‐kinase than fasudil, with a <italic toggle="yes">K</italic>
<sub>i</sub> ranging from 0.039 to 1.8 μM (Jacobs et al., <xref rid="tjp15095-bib-0034" ref-type="bibr">2006</xref>; Rikitake et al., <xref rid="tjp15095-bib-0061" ref-type="bibr">2005</xref>; Satoh et al., <xref rid="tjp15095-bib-0064" ref-type="bibr">2012</xref>; Shibuya et al., <xref rid="tjp15095-bib-0066" ref-type="bibr">2005</xref>; Shimokawa, <xref rid="tjp15095-bib-0068" ref-type="bibr">2002</xref>; Shimokawa et al., <xref rid="tjp15095-bib-0069" ref-type="bibr">1999</xref>) compared to 140 μM for myosin light chain kinase (Satoh et al., <xref rid="tjp15095-bib-0064" ref-type="bibr">2012</xref>), 2.2–37 μM for protein kinase A (Jacobs et al., <xref rid="tjp15095-bib-0034" ref-type="bibr">2006</xref>; Rikitake et al., <xref rid="tjp15095-bib-0061" ref-type="bibr">2005</xref>; Satoh et al., <xref rid="tjp15095-bib-0064" ref-type="bibr">2012</xref>) and 18−100 μM for protein kinase C (Rikitake et al., <xref rid="tjp15095-bib-0061" ref-type="bibr">2005</xref>; Satoh et al., <xref rid="tjp15095-bib-0064" ref-type="bibr">2012</xref>; Shimokawa et al., <xref rid="tjp15095-bib-0069" ref-type="bibr">1999</xref>), and it has a significantly longer half‐life in circulation compared to fasudil (over 4 h <italic toggle="yes">vs</italic>. less than 1 h) (Shibuya et al., <xref rid="tjp15095-bib-0066" ref-type="bibr">2005</xref>). Given that plasma [fasudil] and [hydroxyfasudil] in the present study were within the <italic toggle="yes">K</italic>
<sub>i</sub> range specific for Rho‐kinase, it is unlikely that any effects of fasudil in the present study were due to off‐target effects of these compounds.</p>
              </sec>
              <sec id="tjp15095-sec-0280">
                <title>Experimental considerations</title>
                <p>Given our study design in which the order of saline and fasudil study days were randomized, and that there is some day‐to‐day variability in forearm haemodynamics, absolute levels of FBF and FVC were not always significant between groups. This was observed during the hypoxia trial, but when the data are expressed as a response from baseline (i.e. Δ FBF or FVC) to account for individual differences in baseline haemodynamics, there is a clear age‐related impairment in hypoxic vasodilatation that is reversed with fasudil (Fig. <xref rid="tjp15095-fig-0002" ref-type="fig">2</xref>). During graded handgrip exercise, a similar observation was made during 15% MVC exercise, but a reduction in FBF and FVC was observed during 25% MVC exercise in older adults whether expressed as absolute levels or a change from baseline (Fig. <xref rid="tjp15095-fig-0003" ref-type="fig">3</xref>). Finally, independent of how the forearm haemodynamic data are expressed, Rho‐kinase inhibition with fasudil clearly improved the responses to hypoxia and moderate intensity handgrip exercise in older adults only.</p>
                <p>Another important experimental consideration is that the effect of Rho‐kinase inhibition on vascular tone and blood flow in older adults during exercise was specific to moderate intensity rhythmic handgrip exercise. Additionally, the age group difference in absolute levels of muscle blood flow and vascular conductance during exercise was ∼18% and 29%, respectively, consistent with prior studies on this topic (for review see Hearon Jr. &amp; Dinenno, <xref rid="tjp15095-bib-0031" ref-type="bibr">2016</xref>). Future studies will be required to determine whether Rho‐kinase inhibition improves exercising muscle haemodynamics during larger muscle mass (e.g. knee extensor) or more conventional exercise modalities (e.g. cycling), and whether any increase in muscle blood flow and vascular conductance results in improved exercise capacity or tolerance, to ascertain the therapeutic potential of pharmacologically induced Rho‐kinase inhibition in older and/or diseased humans.</p>
              </sec>
              <sec id="tjp15095-sec-0290">
                <title>Conclusions</title>
                <p>This investigation provides the first experimental evidence that age‐related impairments in the peripheral vasodilatory and hyperaemic responses to systemic hypoxia and moderate intensity rhythmic handgrip exercise can be significantly improved by Rho‐kinase inhibition in humans, and that this is accompanied by improvements in circulating ATP during these physiological stimuli. These findings also provide the necessary foundation for performing future investigations to determine the underlying mechanisms by which Rho‐kinase inhibition improves these haemodynamic responses in healthy older adults. Thus, Rho‐kinase inhibition and/or targeting RBC ATP release may be a promising therapeutic target for improving blood flow and oxygen delivery in older adults, and for ultimately ameliorating the age‐related declines in exercise tolerance and functional independence associated with impaired vascular function with advancing age and various patient populations.</p>
              </sec>
            </sec>
            <sec id="tjp15095-sec-0300">
              <title>Additional information</title>
            </sec>
            <sec id="tjp15095-sec-0330">
              <sec disp-level="2" id="tjp15095-sec-0340">
                <title>Competing interests</title>
                <p>None.</p>
              </sec>
              <sec disp-level="2" id="tjp15095-sec-0350">
                <title>Author contributions</title>
                <p>All experiments were performed in the Human Cardiovascular Physiology Laboratory, Colorado State University, Fort Collins, CO, USA. M.L.R., J.D.T., N.B.K., N.P.B., J.C.R. and F.A.D. contributed to conception and design of the experiments, data collection, analysis, and interpretation, and writing/revising the manuscript. G.J.L. contributed to the experimental design, data collection, and critical revision of the manuscript. All authors approved the final version of the manuscript and agree to be accountable for all aspects of the work. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed.</p>
              </sec>
              <sec disp-level="2" id="tjp15095-sec-0360">
                <title>Funding</title>
                <p>This research was supported by the National Institutes of Health awards HL119337 (F.A.D., M.J.J.) and F31HL126377 (M.L.R., F.A.D.).</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="tjp15095-supitem-0001" position="float" content-type="local-data">
                <caption>
                  <p>
Peer Review History
</p>
                </caption>
                <media xlink:href="TJP-600-3265-s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="tjp15095-supitem-0002" position="float" content-type="local-data">
                <caption>
                  <p>
Statistical Summary Document
</p>
                </caption>
                <media xlink:href="TJP-600-3265-s001.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="tjp15095-sec-0370">
              <title>Acknowledgements</title>
              <p>We thank the subjects who volunteered to participate and all laboratory volunteers for their assistance in conducting these studies.</p>
            </ack>
            <bio id="d96e47">
              <p><bold>Matthew L. Racine</bold> received his undergraduate degree from the University of Idaho (2009), MS from the University of Colorado Boulder (2012), and PhD from Colorado State University (2018). As a Pre‐Doctoral Ruth L. Kirschstein National Research Service Award Fellow trained under Dr Frank Dinenno in the Human Cardiovascular Physiology Laboratory at CSU, his research on the mechanisms of skeletal muscle blood flow regulation during physiological stressors such as exercise and hypoxia in young and older adults focused on the contribution of red blood cells to this process through the release of ATP.</p>
              <graphic xlink:href="TJP-600-3265-g004.gif" position="anchor" id="jats-graphic-1"/>
            </bio>
            <sec sec-type="data-availability" id="tjp15095-sec-0320">
              <title>Data availability statement</title>
              <p>All data supporting the results presented in the manuscript are included in the manuscript figures (<italic toggle="yes">n</italic> ≤ 30), as per <italic toggle="yes">The Journal</italic>’s Statistics Policy.</p>
            </sec>
            <ref-list id="tjp15095-bibl-0001">
              <title>References</title>
              <ref id="tjp15095-bib-0001">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0001"><string-name><surname>Banzett</surname>, <given-names>R. B.</given-names></string-name>, <string-name><surname>Garcia</surname>, <given-names>R. T.</given-names></string-name>, &amp; <string-name><surname>Moosavi</surname>, <given-names>S. H.</given-names></string-name> (<year>2000</year>). <article-title>Simple contrivance “clamps” end‐tidal PCO<sub>2</sub> and PO<sub>2</sub> despite rapid changes in ventilation</article-title>. <source>Journal of Applied Physiology</source>, <volume>88</volume>(<issue>5</issue>), <fpage>1597</fpage>–<lpage>1600</lpage>.<pub-id pub-id-type="pmid">10797118</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0002">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0002"><string-name><surname>Barrett‐O'Keefe</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Ives</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Trinity</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Morgan</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Rossman</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Donato</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Runnels</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Morgan</surname>, <given-names>D. E.</given-names></string-name>, <string-name><surname>Gmelch</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Bledsoe</surname>, <given-names>A. D.</given-names></string-name>, <string-name><surname>Richardson</surname>, <given-names>R. S.</given-names></string-name>, &amp; <string-name><surname>Wray</surname>, <given-names>D. W.</given-names></string-name> (<year>2015</year>). <article-title>Endothelin‐A‐mediated vasoconstriction during exercise with advancing age</article-title>. <source>Journals of Gerontology Biological Sciences</source>, <volume>70</volume>(<issue>5</issue>), <fpage>554</fpage>–<lpage>565</lpage>.</mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0003">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0003"><string-name><surname>Benjamin</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Blaha</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Chiuve</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Cushman</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Das</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Deo</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>de Ferranti</surname>, <given-names>S. D.</given-names></string-name>, <string-name><surname>Floyd</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fornage</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gillespie</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Isasi</surname>, <given-names>C. R.</given-names></string-name>, <string-name><surname>Jiménez</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Jordan</surname>, <given-names>L. C.</given-names></string-name>, <string-name><surname>Judd</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Lackland</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Lichtman</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Lisabeth</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Longenecker</surname>, <given-names>C. T.</given-names></string-name>, … <string-name><surname>Muntner</surname>, <given-names>P.</given-names></string-name>, <collab collab-type="authors">American Heart Association Statistics Committee and Stroke Statistics Subcommittee</collab>
(<year>2017</year>). <article-title>Heart disease and stroke statistics—2017 update: A report from the American Heart Association</article-title>. <source>Circulation</source>, <volume>135</volume>(<issue>10</issue>), <fpage>e146</fpage>–<lpage>e603</lpage>.<pub-id pub-id-type="pmid">28122885</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0004">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0004"><string-name><surname>Bergfeld</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name><surname>Forrester</surname>, <given-names>T.</given-names></string-name> (<year>1992</year>). <article-title>Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia</article-title>. <source>Cardiovascular Research</source>, <volume>26</volume>(<issue>1</issue>), <fpage>40</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">1325292</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0005">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0005"><string-name><surname>Blitzer</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S. D.</given-names></string-name>, &amp; <string-name><surname>Creager</surname>, <given-names>M. A.</given-names></string-name> (<year>1996</year>). <article-title>Endothelium‐derived nitric oxide mediates hypoxic vasodilation of resistance vessels in humans</article-title>. <source>American Journal of Physiology</source>, <volume>271</volume>, <fpage>H1182</fpage>–<lpage>H1185</lpage>.<pub-id pub-id-type="pmid">8853358</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0006">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0006"><string-name><surname>Büssemaker</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Pistrosch</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Förster</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Herbrig</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Gross</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Passauer</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Brandes</surname>, <given-names>R. P.</given-names></string-name> (<year>2007</year>). <article-title>Rho kinase contributes to basal vascular tone in humans: role of endothelium‐derived nitric oxide</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>293</volume>(<issue>1</issue>), <fpage>H541</fpage>–<lpage>H547</lpage>.<pub-id pub-id-type="pmid">17384125</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0007">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0007"><string-name><surname>Campanella</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Chu</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Low</surname>, <given-names>P. S.</given-names></string-name> (<year>2005</year>). <article-title>Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane</article-title>. <source>Proceedings of the National Academy of Sciences, USA</source>, <volume>102</volume>(<issue>7</issue>), <fpage>2402</fpage>–<lpage>2407</lpage>.</mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0008">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0008"><string-name><surname>Casey</surname>, <given-names>D. P.</given-names></string-name>, <string-name><surname>Madery</surname>, <given-names>B. D.</given-names></string-name>, <string-name><surname>Curry</surname>, <given-names>T. B.</given-names></string-name>, <string-name><surname>Eisenach</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Wilkins</surname>, <given-names>B. W.</given-names></string-name>, &amp; <string-name><surname>Joyner</surname>, <given-names>M. J.</given-names></string-name> (<year>2010</year>). <article-title>Nitric oxide contributes to the augmented vasodilatation during hypoxic exercise</article-title>. <source>Journal of Physiology</source>, <volume>588</volume>(<issue>2</issue>), <fpage>373</fpage>–<lpage>385</lpage>.<pub-id pub-id-type="pmid">19948661</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0009">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0009"><string-name><surname>Casey</surname>, <given-names>D. P.</given-names></string-name>, <string-name><surname>Walker</surname>, <given-names>B. G.</given-names></string-name>, <string-name><surname>Curry</surname>, <given-names>T. B.</given-names></string-name>, &amp; <string-name><surname>Joyner</surname>, <given-names>M. J.</given-names></string-name> (<year>2011</year>). <article-title>Ageing reduces the compensatory vasodilatation during hypoxic exercise: The role of nitric oxide</article-title>. <source>Journal of Physiology</source>, <volume>589</volume>(<issue>6</issue>), <fpage>1477</fpage>–<lpage>1488</lpage>.<pub-id pub-id-type="pmid">21282292</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0010">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0010"><string-name><surname>Chen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bai</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Wen</surname>, <given-names>S.</given-names></string-name> (<year>2010</year>). <article-title>Simultaneous quantitative analysis of fasudil and its active metabolite in human plasma by liquid chromatography electro‐spray tandem mass spectrometry</article-title>. <source>Journal of Pharmaceutical and Biomedical Analysis</source>, <volume>52</volume>(<issue>2</issue>), <fpage>242</fpage>–<lpage>248</lpage>.<pub-id pub-id-type="pmid">20080374</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0011">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0011"><string-name><surname>Clifford</surname>, <given-names>P. S.</given-names></string-name>, &amp; <string-name><surname>Hellsten</surname>, <given-names>Y.</given-names></string-name> (<year>2004</year>). <article-title>Vasodilatory mechanisms in contracting skeletal muscle</article-title>. <source>Journal of Applied Physiology</source>, <volume>97</volume>(<issue>1</issue>), <fpage>393</fpage>–<lpage>403</lpage>.<pub-id pub-id-type="pmid">15220322</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0012">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0012"><string-name><surname>Collins</surname>, <given-names>D. M.</given-names></string-name>, <string-name><surname>McCullough</surname>, <given-names>W. T.</given-names></string-name>, &amp; <string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name> (<year>1998</year>). <article-title>Conducted vascular responses: Communication across the capillary bed</article-title>. <source>Microvascular Research</source>, <volume>56</volume>(<issue>1</issue>), <fpage>43</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">9683562</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0013">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0013"><string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Kirby</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Luckasen</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Larson</surname>, <given-names>D. G.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2012</year>). <article-title>ATP‐mediated vasodilatation occurs via activation of inwardly rectifying potassium channels in humans</article-title>. <source>Journal of Physiology</source>, <volume>590</volume>(<issue>21</issue>), <fpage>5349</fpage>–<lpage>5359</lpage>.<pub-id pub-id-type="pmid">22777673</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0014">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0014"><string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Kirby</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Richards</surname>, <given-names>J. C.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2013</year>). <article-title>Mechanical effects of muscle contraction increase intravascular ATP draining quiescent and active skeletal muscle in humans</article-title>. <source>Journal of Applied Physiology</source>, <volume>114</volume>(<issue>8</issue>), <fpage>1085</fpage>–<lpage>1093</lpage>.<pub-id pub-id-type="pmid">23429876</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0015">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0015"><string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Kirby</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Voyles</surname>, <given-names>W. F.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2010</year>). <article-title>Nitric oxide, but not vasodilating prostaglandins, contributes to the improvement of exercise hyperemia via ascorbic acid in healthy older adults</article-title>. <source>American Journal of Physiology Heart and Circulatory Physiology</source>, <volume>299</volume>(<issue>5</issue>), <fpage>H1633</fpage>–<lpage>H1641</lpage>.<pub-id pub-id-type="pmid">20817831</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0016">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0016"><string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Kirby</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Voyles</surname>, <given-names>W. F.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2011</year>). <article-title>Augmented skeletal muscle hyperaemia during hypoxic exercise in humans is blunted by combined inhibition of nitric oxide and vasodilating prostaglandins</article-title>. <source>Journal of Physiology</source>, <volume>589</volume>(<issue>14</issue>), <fpage>3671</fpage>–<lpage>3683</lpage>.<pub-id pub-id-type="pmid">21624968</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0017">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0017"><string-name><surname>Davies</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Reddy</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Caivano</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Cohen</surname>, <given-names>P.</given-names></string-name> (<year>2000</year>). <article-title>Specificity and mechanism of action of some commonly used protein kinase inhibitors</article-title>. <source>Biochemical Journal</source>, <volume>351</volume>(<issue>1</issue>), <fpage>95</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="pmid">10998351</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0018">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0018"><string-name><surname>Dietrich</surname>, <given-names>H. H.</given-names></string-name>, <string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Sprague</surname>, <given-names>R. S.</given-names></string-name>, &amp; <string-name><surname>Dacey</surname>, <given-names>R. G.</given-names></string-name> (<year>2000</year>). <article-title>Red blood cell regulation of microvascular tone through adenosine triphosphate</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>278</volume>(<issue>4</issue>), <fpage>H1294</fpage>‐<lpage>H1298</lpage>.<pub-id pub-id-type="pmid">10749727</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0019">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0019"><string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name>, &amp; <string-name><surname>Joyner</surname>, <given-names>M. J.</given-names></string-name> (<year>2003</year>). <article-title>Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: Is nitric oxide obligatory?</article-title>
<source>Journal of Physiology</source>, <volume>553</volume>(<issue>1</issue>), <fpage>281</fpage>–<lpage>292</lpage>.<pub-id pub-id-type="pmid">12949223</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0020">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0020"><string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name>, &amp; <string-name><surname>Joyner</surname>, <given-names>M. J.</given-names></string-name> (<year>2004</year>). <article-title>Combined NO and PG inhibition augments alpha‐adrenergic vasoconstriction in contracting human skeletal muscle</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>287</volume>(<issue>6</issue>), <fpage>H2576</fpage>–<lpage>H2584</lpage>.<pub-id pub-id-type="pmid">15271659</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0021">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0021"><string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name>, &amp; <string-name><surname>Joyner</surname>, <given-names>M. J.</given-names></string-name> (<year>2006</year>). <article-title>Alpha‐adrenergic control of skeletal muscle circulation at rest and during exercise in aging humans</article-title>. <source>Microcirculation</source>, <volume>13</volume>(<issue>4</issue>), <fpage>329</fpage>–<lpage>341</lpage>.<pub-id pub-id-type="pmid">16611594</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0022">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0022"><string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name>, <string-name><surname>Joyner</surname>, <given-names>M. J.</given-names></string-name>, &amp; <string-name><surname>Halliwill</surname>, <given-names>J. R.</given-names></string-name> (<year>2003</year>). <article-title>Failure of systemic hypoxia to blunt alpha‐adrenergic vasoconstriction in the human forearm</article-title>. <source>Journal of Physiology</source>, <volume>549</volume>(<issue>3</issue>), <fpage>985</fpage>–<lpage>994</lpage>.<pub-id pub-id-type="pmid">12730336</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0023">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0023"><string-name><surname>Dora</surname>, <given-names>K. A.</given-names></string-name> (<year>2017</year>). <article-title>Conducted dilatation to ATP and K+ and in rat skeletal muscle arterioles</article-title>. <source>Acta Physiologica</source>, <volume>219</volume>(<issue>1</issue>), <fpage>202</fpage>–<lpage>218</lpage>.<pub-id pub-id-type="pmid">26804547</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0024">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0024"><string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name> (<year>2000</year>). <article-title>The red blood cell as an oxygen sensor: what is the evidence?</article-title>
<source>Acta Physiologica Scandinavica</source>, <volume>168</volume>(<issue>4</issue>), <fpage>551</fpage>–<lpage>559</lpage>.<pub-id pub-id-type="pmid">10759592</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0025">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0025"><string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Forrester</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Ellis</surname>, <given-names>C. G.</given-names></string-name>, &amp; <string-name><surname>Dietrich</surname>, <given-names>H. H.</given-names></string-name> (<year>1995</year>). <article-title>The erythrocyte as a regulator of vascular tone</article-title>. <source>American Journal of Physiology</source>, <volume>269</volume>, <fpage>H2155</fpage>–<lpage>H2161</lpage>.<pub-id pub-id-type="pmid">8594927</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0026">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0026"><string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name>, &amp; <string-name><surname>Sprague</surname>, <given-names>R. S.</given-names></string-name> (<year>2012</year>). <article-title>Regulation of blood flow distribution in skeletal muscle: Role of erythrocyte‐released ATP</article-title>. <source>Journal of Physiology</source>, <volume>590</volume>(<issue>20</issue>), <fpage>4985</fpage>–<lpage>4991</lpage>.<pub-id pub-id-type="pmid">22586223</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0027">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0027"><string-name><surname>Giannarelli</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Virdis</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>De Negri</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Magagna</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Duranti</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Salvetti</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Taddei</surname>, <given-names>S.</given-names></string-name> (<year>2009</year>). <article-title>Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients</article-title>. <source>Circulation</source>, <volume>119</volume>(<issue>12</issue>), <fpage>1625</fpage>–<lpage>1633</lpage>.<pub-id pub-id-type="pmid">19289643</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0028">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0028"><string-name><surname>González‐Alonso</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Olsen</surname>, <given-names>D. B.</given-names></string-name>, &amp; <string-name><surname>Saltin</surname>, <given-names>B.</given-names></string-name> (<year>2002</year>). <article-title>Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: Role of circulating ATP</article-title>. <source>Circulation Research</source>, <volume>91</volume>(<issue>11</issue>), <fpage>1046</fpage>–<lpage>1055</lpage>.<pub-id pub-id-type="pmid">12456491</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0029">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0029"><string-name><surname>Gorman</surname>, <given-names>M. W.</given-names></string-name>, <string-name><surname>Feigl</surname>, <given-names>E. O.</given-names></string-name>, &amp; <string-name><surname>Buffington</surname>, <given-names>C. W.</given-names></string-name> (<year>2007</year>). <article-title>Human plasma ATP concentration</article-title>. <source>Clinical Chemistry</source>, <volume>53</volume>(<issue>2</issue>), <fpage>318</fpage>–<lpage>325</lpage>.<pub-id pub-id-type="pmid">17185366</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0030">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0030"><string-name><surname>Gorman</surname>, <given-names>M. W.</given-names></string-name>, <string-name><surname>Marble</surname>, <given-names>D. R.</given-names></string-name>, <string-name><surname>Ogimoto</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Feigl</surname>, <given-names>E. O.</given-names></string-name> (<year>2003</year>). <article-title>Measurement of adenine nucleotides in plasma</article-title>. <source>Luminescence</source>, <volume>18</volume>(<issue>3</issue>), <fpage>173</fpage>–<lpage>181</lpage>.<pub-id pub-id-type="pmid">12701093</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0031">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0031"><string-name><surname>Hearon</surname>, <suffix>Jr.</suffix><given-names>C.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F.</given-names></string-name>. (<year>2016</year>). <article-title>Regulation of skeletal muscle blood flow during exercise in ageing humans</article-title>. <source>Journal of Physiology</source>, <volume>594</volume>(<issue>8</issue>), <fpage>2261</fpage>–<lpage>2273</lpage>.<pub-id pub-id-type="pmid">26332887</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0032">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0032"><string-name><surname>Hearon</surname>, <suffix>Jr.</suffix><given-names>C. M.</given-names></string-name>, <string-name><surname>Richards</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Racine</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Luckasen</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Larson</surname>, <given-names>D. G.</given-names></string-name>, <string-name><surname>Joyner</surname>, <given-names>M. J.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2017</year>). <article-title>Sympatholytic effect of intravascular ATP is independent of nitric oxide, prostaglandins, Na<sup>+</sup>/K<sup>+</sup>‐ATPase and KIR channels in humans</article-title>. <source>Journal of Physiology</source>, <volume>595</volume>(<issue>15</issue>), <fpage>5175</fpage>–<lpage>5190</lpage>.<pub-id pub-id-type="pmid">28590059</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0033">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0033"><string-name><surname>Hellsten</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Nyberg</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jensen</surname>, <given-names>L. G.</given-names></string-name>, &amp; <string-name><surname>Mortensen</surname>, <given-names>S. P.</given-names></string-name> (<year>2012</year>). <article-title>Vasodilator interactions in skeletal muscle blood flow regulation</article-title>. <source>Journal of Physiology</source>, <volume>590</volume>(<issue>24</issue>), <fpage>6297</fpage>–<lpage>6305</lpage>.<pub-id pub-id-type="pmid">22988140</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0034">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0034"><string-name><surname>Jacobs</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hayakawa</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Swenson</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Bellon</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Fleming</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Taslimi</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Doran</surname>, <given-names>J.</given-names></string-name> (<year>2006</year>). <article-title>The structure of dimeric ROCK I reveals the mechanism for ligand selectivity</article-title>. <source>Journal of Biological Chemistry</source>, <volume>281</volume>(<issue>1</issue>), <fpage>260</fpage>–<lpage>268</lpage>.<pub-id pub-id-type="pmid">16249185</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0035">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0035"><string-name><surname>Jagger</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Bateman</surname>, <given-names>R. M.</given-names></string-name>, <string-name><surname>Ellsworth</surname>, <given-names>M.L.</given-names></string-name>, &amp; <string-name><surname>Ellis</surname>, <given-names>C. G.</given-names></string-name> (<year>2001</year>). <article-title>Role of erythrocyte in regulating local O<sub>2</sub> delivery mediated by hemoglobin oxygenation</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>280</volume>(<issue>6</issue>), <fpage>H2833</fpage>–<lpage>H2839</lpage>.<pub-id pub-id-type="pmid">11356642</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0036">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0036"><string-name><surname>Jensen</surname>, <given-names>F. B.</given-names></string-name> (<year>2009</year>). <article-title>The dual roles of red blood cells in tissue oxygen delivery: Oxygen carriers and regulators of local blood flow</article-title>. <source>Journal of Experimental Biology</source>, <volume>212</volume>(<issue>21</issue>), <fpage>3387</fpage>–<lpage>3393</lpage>.<pub-id pub-id-type="pmid">19837879</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0037">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0037"><string-name><surname>Jiang</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ai</surname>, <given-names>Z. ‐S.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Ping</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>Q. ‐H.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Gomberg‐Maitland</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Jing</surname>, <given-names>Z. ‐C.</given-names></string-name> (<year>2015</year>). <article-title>Intravenous fasudil improves in‐hospital mortality of patients with right heart failure in severe pulmonary hypertension</article-title>. <source>Hypertension Research</source>, <volume>38</volume>(<issue>8</issue>), <fpage>539</fpage>–<lpage>544</lpage>.<pub-id pub-id-type="pmid">25787034</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0038">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0038"><string-name><surname>Keller</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Diederich</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Panknin</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>DeLalio</surname>, <given-names>L. J.</given-names></string-name>, <string-name><surname>Drake</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Sherman</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Jackson</surname>, <given-names>E. K.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Kelm</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cortese‐Krott</surname>, <given-names>M. M.</given-names></string-name>, &amp; <string-name><surname>Isakson</surname>, <given-names>B. E.</given-names></string-name> (<year>2017</year>). <article-title>Possible roles for ATP release from RBCs exclude the cAMP‐mediated Panx1 pathway</article-title>. <source>American Journal of Physiology. Cell Physiology</source>, <volume>313</volume>(<issue>6</issue>), <fpage>C593</fpage>–<lpage>C603</lpage>.<pub-id pub-id-type="pmid">28855161</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0039">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0039"><string-name><surname>Kirby</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Voyles</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Simpson</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Carlson</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Schrage</surname>, <given-names>W.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2009</year>). <article-title>Endothelium‐dependent vasodilatation and exercise hyperaemia in ageing humans: Impact of acute ascorbic acid administration</article-title>. <source>Journal of Physiology</source>, <volume>587</volume>(<issue>9</issue>), <fpage>1989</fpage>–<lpage>2003</lpage>.<pub-id pub-id-type="pmid">19307300</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0040">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0040"><string-name><surname>Kirby</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Richards</surname>, <given-names>J. C.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2013</year>). <article-title>Sources of intravascular ATP during exercise in humans: Critical role for skeletal muscle perfusion</article-title>. <source>Experimental Physiology</source>, <volume>98</volume>(<issue>5</issue>), <fpage>988</fpage>–<lpage>998</lpage>.<pub-id pub-id-type="pmid">23315195</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0041">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0041"><string-name><surname>Kirby</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Voyles</surname>, <given-names>W. F.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2010</year>). <article-title>Vasodilatory responsiveness to adenosine triphosphate in ageing humans</article-title>. <source>Journal of Physiology</source>, <volume>588</volume>(<issue>20</issue>), <fpage>4017</fpage>–<lpage>4027</lpage>.<pub-id pub-id-type="pmid">20807789</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0042">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0042"><string-name><surname>Kirby</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Voyles</surname>, <given-names>W. F.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2012</year>). <article-title>Impaired skeletal muscle blood flow control with advancing age in humans: Attenuated ATP release and local vasodilation during erythrocyte deoxygenation</article-title>. <source>Circulation Research</source>, <volume>111</volume>(<issue>2</issue>), <fpage>220</fpage>–<lpage>230</lpage>.<pub-id pub-id-type="pmid">22647875</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0043">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0043"><string-name><surname>Kirby</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Hanna</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Hendargo</surname>, <given-names>H. C.</given-names></string-name>, &amp; <string-name><surname>McMahon</surname>, <given-names>T. J.</given-names></string-name> (<year>2014</year>). <article-title>Restoration of intracellular ATP production in banked red blood cells improves inducible ATP export and suppresses RBC‐endothelial adhesion</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>307</volume>(<issue>12</issue>), <fpage>H1737</fpage>–<lpage>H1744</lpage>.<pub-id pub-id-type="pmid">25305182</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0044">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0044"><string-name><surname>Kirby</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Voyles</surname>, <given-names>W. F.</given-names></string-name>, <string-name><surname>Carlson</surname>, <given-names>R. E.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2008</year>). <article-title>Graded sympatholytic effect of exogenous ATP on postjunctional alpha‐adrenergic vasoconstriction in the human forearm: Implications for vascular control in contracting muscle</article-title>. <source>Journal of Physiology</source>, <volume>586</volume>(<issue>17</issue>), <fpage>4305</fpage>–<lpage>4316</lpage>.<pub-id pub-id-type="pmid">18617568</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0045">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0045"><string-name><surname>Laughlin</surname>, <given-names>M. H.</given-names></string-name>, <string-name><surname>Davis</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Secher</surname>, <given-names>N. H.</given-names></string-name>, <string-name><surname>van Lieshout</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>Arce‐Esquivel</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Simmons</surname>, <given-names>G. H.</given-names></string-name>, <string-name><surname>Bender</surname>, <given-names>S. B.</given-names></string-name>, <string-name><surname>Padilla</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Bache</surname>, <given-names>R. J.</given-names></string-name>, <string-name><surname>Merkus</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Duncker</surname>, <given-names>D. J.</given-names></string-name> (<year>2012</year>). <article-title>Peripheral circulation</article-title>. <source>Comprehensive Physiology</source>, <volume>2</volume>, <fpage>321</fpage>–<lpage>447</lpage>.<pub-id pub-id-type="pmid">23728977</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0046">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0046"><string-name><surname>Lewis</surname>, <given-names>I. A.</given-names></string-name>, <string-name><surname>Campanella</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Markley</surname>, <given-names>J. L.</given-names></string-name>, &amp; <string-name><surname>Low</surname>, <given-names>P. S.</given-names></string-name> (<year>2009</year>). <article-title>Role of band 3 in regulating metabolic flux of red blood cells</article-title>. <source>Proceedings of the National Academy of Sciences, USA</source>, <volume>106</volume>(<issue>44</issue>), <fpage>18515</fpage>–<lpage>18520</lpage>.</mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0047">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0047"><string-name><surname>Löhn</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Steioff</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Bleich</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Busch</surname>, <given-names>A. E.</given-names></string-name>, &amp; <string-name><surname>Ivashchenko</surname>, <given-names>Y.</given-names></string-name> (<year>2005</year>). <article-title>Inhibition of Rho‐kinase stimulates nitric oxide‐independent vasorelaxation</article-title>. <source>European Journal of Pharmacology</source>, <volume>507</volume>(<issue>1–3</issue>), <fpage>179</fpage>–<lpage>186</lpage>.<pub-id pub-id-type="pmid">15659308</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0048">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0048"><string-name><surname>Markwald</surname>, <given-names>R. R.</given-names></string-name>, <string-name><surname>Kirby</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Carlson</surname>, <given-names>R. E.</given-names></string-name>, <string-name><surname>Voyles</surname>, <given-names>W. F.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2011</year>). <article-title>Combined inhibition of nitric oxide and vasodilating prostaglandins abolishes forearm vasodilatation to systemic hypoxia in healthy humans</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>589</volume>, <fpage>H1979</fpage>–<lpage>H1990</lpage>.</mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0049">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0049"><string-name><surname>Messana</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Orlando</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cassiano</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Pennacchietti</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zuppi</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Castagnola</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Giardina</surname>, <given-names>B.</given-names></string-name> (<year>1996</year>). <article-title>Human erythrocyte metabolism is modulated by the O<sub>2</sub>‐linked transition of hemoglobin</article-title>. <source>FEBS Letters</source>, <volume>390</volume>(<issue>1</issue>), <fpage>25</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">8706822</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0050">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0050"><string-name><surname>Mortensen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Nyberg</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Winding</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Saltin</surname>, <given-names>B.</given-names></string-name> (<year>2012</year>). <article-title>Lifelong physical activity preserves functional sympatholysis and purinergic signalling in the ageing human leg</article-title>. <source>Journal of Physiology</source>, <volume>590</volume>(<issue>23</issue>), <fpage>6227</fpage>–<lpage>6236</lpage>.<pub-id pub-id-type="pmid">22966164</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0051">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0051"><string-name><surname>Mortensen</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Saltin</surname>, <given-names>B.</given-names></string-name> (<year>2014</year>). <article-title>Regulation of the skeletal muscle blood flow in humans</article-title>. <source>Experimental Physiology</source>, <volume>99</volume>(<issue>12</issue>), <fpage>1552</fpage>–<lpage>1558</lpage>.<pub-id pub-id-type="pmid">25192730</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0052">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0052"><string-name><surname>Mortensen</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Thaning</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Nyberg</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Saltin</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name><surname>Hellsten</surname>, <given-names>Y.</given-names></string-name> (<year>2011</year>). <article-title>Local release of ATP into the arterial inflow and venous drainage of human skeletal muscle: Insight from ATP determination with the intravascular microdialysis technique</article-title>. <source>Journal of Physiology</source>, <volume>589</volume>(<issue>7</issue>), <fpage>1847</fpage>–<lpage>1857</lpage>.<pub-id pub-id-type="pmid">21300753</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0053">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0053"><string-name><surname>Proctor</surname>, <given-names>D.N.</given-names></string-name>, &amp; <string-name><surname>Parker</surname>, <given-names>B. A.</given-names></string-name> (<year>2006</year>). <article-title>Vasodilation and vascular control in contracting muscle of the aging human</article-title>. <source>Microcirculation</source>, <volume>13</volume>(<issue>4</issue>), <fpage>315</fpage>–<lpage>327</lpage>.<pub-id pub-id-type="pmid">16611597</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0054">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0054"><string-name><surname>Racine</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Luckasen</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Larson</surname>, <given-names>D. G.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2018</year>). <article-title>Inhibition of Na+/K+‐ATPase and KIR channels abolishes hypoxic hyperaemia in resting but not contracting skeletal muscle of humans</article-title>. <source>Journal of Physiology</source>, <volume>596</volume>(<issue>15</issue>), <fpage>3371</fpage>–<lpage>3389</lpage>.<pub-id pub-id-type="pmid">29603743</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0055">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0055"><string-name><surname>Racine</surname>, <given-names>M. L.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2019</year>). <article-title>Reduced deformability contributes to impaired deoxygenation‐induced ATP release from red blood cells of older adult humans</article-title>. <source>Journal of Physiology</source>, <volume>597</volume>(<issue>17</issue>), <fpage>4503</fpage>–<lpage>4519</lpage>.<pub-id pub-id-type="pmid">31310005</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0056">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0056"><string-name><surname>Richards</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Larson</surname>, <given-names>D. G.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2015</year>). <article-title>Acute ascorbic acid ingestion increases skeletal muscle blood flow and oxygen consumption via local vasodilation during graded handgrip exercise in older adults</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>309</volume>(<issue>2</issue>), <fpage>H360</fpage>–<lpage>H368</lpage>.<pub-id pub-id-type="pmid">25980023</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0057">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0057"><string-name><surname>Richards</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Crecelius</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Larson</surname>, <given-names>D. G.</given-names></string-name>, <string-name><surname>Luckasen</surname>, <given-names>G. J.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2017</year>). <article-title>Impaired peripheral vasodilation during graded systemic hypoxia in healthy older adults: Role of the sympathoadrenal system</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>312</volume>(<issue>4</issue>), <fpage>H832</fpage>–<lpage>H841</lpage>.<pub-id pub-id-type="pmid">28159810</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0058">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0058"><string-name><surname>Richards</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Luckasen</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Larson</surname>, <given-names>D. G.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2014</year>). <article-title>Role of α‐adrenergic vasoconstriction in regulating skeletal muscle blood flow and vascular conductance during forearm exercise in ageing humans</article-title>. <source>Journal of Physiology</source>, <volume>592</volume>(<issue>21</issue>), <fpage>4775</fpage>–<lpage>4788</lpage>.<pub-id pub-id-type="pmid">25194040</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0059">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0059"><string-name><surname>Richards</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Racine</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Hearon</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Kunkel</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Luckasen</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Larson</surname>, <given-names>D. G.</given-names></string-name>, <string-name><surname>Allen</surname>, <given-names>J. D.</given-names></string-name>, &amp; <string-name><surname>Dinenno</surname>, <given-names>F. A.</given-names></string-name> (<year>2018</year>). <article-title>Acute ingestion of dietary nitrate increases muscle blood flow via local vasodilation during handgrip exercise in young adults</article-title>. <source>Physiological Reports</source>, <volume>6</volume>(<issue>2</issue>), <elocation-id>e13572</elocation-id>.</mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0060">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0060"><string-name><surname>Richards</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Stephenson</surname>, <given-names>A. H.</given-names></string-name>, <string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name>, &amp; <string-name><surname>Sprague</surname>, <given-names>R. S.</given-names></string-name> (<year>2013</year>). <article-title>Synergistic effects of C‐peptide and insulin on low O2‐induced ATP release from human erythrocytes</article-title>. <source>American Journal of Physiology. Regulatory, Integrative and Comparative Physiology</source>, <volume>305</volume>(<issue>11</issue>), <fpage>R1331</fpage>‐<lpage>R1336</lpage>.<pub-id pub-id-type="pmid">24089376</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0061">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0061"><string-name><surname>Rikitake</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>H. ‐. H.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Seto</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yano</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Asano</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Moskowitz</surname>, <given-names>M. A.</given-names></string-name>, &amp; <string-name><surname>Liao</surname>, <given-names>J. K.</given-names></string-name> (<year>2005</year>). <article-title>Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection</article-title>. <source>Stroke</source>, <volume>36</volume>(<issue>10</issue>), <fpage>2251</fpage>–<lpage>2257</lpage>.<pub-id pub-id-type="pmid">16141422</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0062">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0062"><string-name><surname>Rosenmeier</surname>, <given-names>J. B.</given-names></string-name>, <string-name><surname>Hansen</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>González‐Alonso</surname>, <given-names>J.</given-names></string-name> (<year>2004</year>). <article-title>Circulating ATP‐induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle</article-title>. <source>Journal of Physiology</source>, <volume>558</volume>(<issue>1</issue>), <fpage>351</fpage>–<lpage>365</lpage>.<pub-id pub-id-type="pmid">15155791</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0063">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0063"><string-name><surname>Satoh</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ikegaki</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Kawasaki</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Asano</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Shibuya</surname>, <given-names>M.</given-names></string-name> (<year>2014</year>). <article-title>Pleiotropic effects of the Rho‐kinase inhibitor fasudil after subarachnoid hemorrhage: A review of preclinical and clinical studies</article-title>. <source>Current Vascular Pharmacology</source>, <volume>12</volume>(<issue>5</issue>), <fpage>758</fpage>–<lpage>765</lpage>.<pub-id pub-id-type="pmid">24923440</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0064">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0064"><string-name><surname>Satoh</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Takayasu</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kawasaki</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ikegaki</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Hitomi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Yano</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Shibuya</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Asano</surname>, <given-names>T.</given-names></string-name> (<year>2012</year>). <article-title>Antivasospastic effects of hydroxyfasudil, a Rho‐kinase inhibitor, after subarachnoid hemorrhage</article-title>. <source>Journal of Pharmacological Sciences</source>, <volume>118</volume>(<issue>1</issue>), <fpage>92</fpage>–<lpage>98</lpage>.</mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0065">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0065"><string-name><surname>Segal</surname>, <given-names>S. S.</given-names></string-name> (<year>2005</year>). <article-title>Regulation of blood flow in the microcirculation</article-title>. <source>Microcirculation</source>, <volume>12</volume>(<issue>1</issue>), <fpage>33</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">15804972</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0066">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0066"><string-name><surname>Shibuya</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hirai</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Seto</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Satoh</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Ohtomo</surname>, <given-names>E.</given-names></string-name> (<year>2005</year>). <article-title>Effects of fasudil in acute ischemic stroke: Results of a prospective placebo‐controlled double‐blind trial</article-title>. <source>Journal of the Neurological Sciences</source>, <volume>238</volume>(<issue>1–2</issue>), <fpage>31</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">16005902</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0067">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0067"><string-name><surname>Shibuya</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Suzuki</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Sugita</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Saito</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Sasaki</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Takakura</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Nagata</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Kikuchi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Takemae</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hidaka</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Nakashima</surname>, <given-names>M.</given-names></string-name> (<year>1992</year>). <article-title>Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Results of a prospective placebo‐controlled double‐blind trial</article-title>. <source>Journal of Neurosurgery</source>, <volume>76</volume>(<issue>4</issue>), <fpage>571</fpage>–<lpage>577</lpage>.<pub-id pub-id-type="pmid">1545249</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0068">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0068"><string-name><surname>Shimokawa</surname>, <given-names>H.</given-names></string-name> (<year>2002</year>). <article-title>Rho‐kinase as a novel therapeutic target in treatment of cardiovascular diseases</article-title>. <source>Journal of Cardiovascular Pharmacology</source>, <volume>39</volume>(<issue>3</issue>), <fpage>319</fpage>–<lpage>327</lpage>.<pub-id pub-id-type="pmid">11862109</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0069">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0069"><string-name><surname>Shimokawa</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Seto</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Katsumata</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Amano</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kozai</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Yamawaki</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kuwata</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Kandabashi</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Egashira</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ikegaki</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Asano</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kaibuchi</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Takeshita</surname>, <given-names>A.</given-names></string-name> (<year>1999</year>). <article-title>Rho‐kinase‐mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm</article-title>. <source>Cardiovascular Research</source>, <volume>43</volume>(<issue>4</issue>), <fpage>1029</fpage>–<lpage>1039</lpage>.<pub-id pub-id-type="pmid">10615430</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0070">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0070"><string-name><surname>Shimokawa</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Sunamura</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Satoh</surname>, <given-names>K.</given-names></string-name> (<year>2016</year>). <article-title>RhoA/Rho‐kinase in the cardiovascular system</article-title>. <source>Circulation Research</source>, <volume>118</volume>(<issue>2</issue>), <fpage>352</fpage>–<lpage>366</lpage>.<pub-id pub-id-type="pmid">26838319</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0071">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0071"><string-name><surname>Sprague</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Bowles</surname>, <given-names>E. A.</given-names></string-name>, <string-name><surname>Achilleus</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Stephenson</surname>, <given-names>A. H.</given-names></string-name>, <string-name><surname>Ellis</surname>, <given-names>C.G.</given-names></string-name>, &amp; <string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name> (<year>2011</year>). <article-title>A selective phosphodiesterase 3 inhibitor rescues low PO<sub>2</sub>‐induced ATP release from erythrocytes of humans with type 2 diabetes: Implication for vascular control</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>301</volume>(<issue>6</issue>), <fpage>H2466</fpage>–<lpage>H2472</lpage>.<pub-id pub-id-type="pmid">21963837</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0072">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0072"><string-name><surname>Sprague</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Stephenson</surname>, <given-names>A. H.</given-names></string-name>, <string-name><surname>Kleinhenz</surname>, <given-names>M. E.</given-names></string-name>, &amp; <string-name><surname>Lonigro</surname>, <given-names>A. J.</given-names></string-name> (<year>1998</year>). <article-title>Deformation‐induced ATP release from red blood cells requires CFTR activity</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>275</volume>(<issue>5</issue>), <fpage>H1726</fpage>–<lpage>H1732</lpage>.</mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0073">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0073"><string-name><surname>Sprague</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Stephenson</surname>, <given-names>A. H.</given-names></string-name>, &amp; <string-name><surname>Lonigro</surname>, <given-names>A. J.</given-names></string-name> (<year>2001</year>). <article-title>Participation of cAMP in a signal‐transduction pathway relating erythrocyte deformation to ATP release</article-title>. <source>American Journal of Physiology. Cell Physiology</source>, <volume>281</volume>(<issue>4</issue>), <fpage>C1158</fpage>–<lpage>C1164</lpage>.<pub-id pub-id-type="pmid">11546651</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0074">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0074"><string-name><surname>Sprague</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Hanson</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Achilleus</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Bowles</surname>, <given-names>E. A.</given-names></string-name>, <string-name><surname>Stephenson</surname>, <given-names>A. H.</given-names></string-name>, <string-name><surname>Sridharan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Adderley</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name> (<year>2009</year>). <article-title>Rabbit erythrocytes release ATP and dilate skeletal muscle arterioles in the presence of reduced oxygen tension</article-title>. <source>Pharmacol Reports</source>, <volume>61</volume>(<issue>1</issue>), <fpage>183</fpage>–<lpage>190</lpage>.</mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0075">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0075"><string-name><surname>Sridharan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Adderley</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Bowles</surname>, <given-names>E. A.</given-names></string-name>, <string-name><surname>Egan</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Stephenson</surname>, <given-names>A. H.</given-names></string-name>, <string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name>, &amp; <string-name><surname>Sprague</surname>, <given-names>R. S.</given-names></string-name> (<year>2010</year>). <article-title>Pannexin 1 is the conduit for low oxygen tension‐induced ATP release from human erythrocytes</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>299</volume>(<issue>4</issue>), <fpage>H1146</fpage>–<lpage>H1152</lpage>.<pub-id pub-id-type="pmid">20622111</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0076">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0076"><string-name><surname>Sridharan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sprague</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Adderley</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Bowles</surname>, <given-names>E. A.</given-names></string-name>, <string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name>, &amp; <string-name><surname>Stephenson</surname>, <given-names>A. H.</given-names></string-name> (<year>2010</year>). <article-title>Diamide decreases deformability of rabbit erythrocytes and attenuates low oxygen tension‐induced ATP release</article-title>. <source>Experimental Biology and Medicine</source>, <volume>235</volume>(<issue>9</issue>), <fpage>1142</fpage>–<lpage>1148</lpage>.<pub-id pub-id-type="pmid">20682601</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0077">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0077"><string-name><surname>Sugimoto</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nakayama</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Goto</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Amano</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Komori</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Kaibuchi</surname>, <given-names>K.</given-names></string-name> (<year>2007</year>). <article-title>Rho‐kinase phosphorylates eNOS at threonine 495 in endothelial cells</article-title>. <source>Biochemical and Biophysical Research Communications</source>, <volume>361</volume>(<issue>2</issue>), <fpage>462</fpage>–<lpage>467</lpage>.<pub-id pub-id-type="pmid">17651694</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0078">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0078"><string-name><surname>Suzuki</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Shibuya</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Satoh</surname>, <given-names>S. ‐. I.</given-names></string-name>, <string-name><surname>Sugimoto</surname>, <given-names>Y.</given-names></string-name>, &amp; <string-name><surname>Takakura</surname>, <given-names>K.</given-names></string-name> (<year>2007</year>). <article-title>A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage</article-title>. <source>Surgical Neurology</source>, <volume>68</volume>(<issue>2</issue>), <fpage>126</fpage>–<lpage>131</lpage>.<pub-id pub-id-type="pmid">17586012</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0079">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0079"><string-name><surname>Suzuki</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Shibuya</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Satoh</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sugiyama</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Seto</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Takakura</surname>, <given-names>K.</given-names></string-name> (<year>2008</year>). <article-title>Safety and efficacy of fasudil monotherapy and fasudil‐ozagrel combination therapy in patients with subarachnoid hemorrhage: Sub‐analysis of the post‐marketing surveillance study</article-title>. <source>Neurologia Medico‐Chirurgica</source>, <volume>48</volume>(<issue>6</issue>), <fpage>241</fpage>–<lpage>248</lpage>.<pub-id pub-id-type="pmid">18574328</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0080">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0080"><string-name><surname>Thuet</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Bowles</surname>, <given-names>E. A.</given-names></string-name>, <string-name><surname>Ellsworth</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Sprague</surname>, <given-names>R. S.</given-names></string-name>, &amp; <string-name><surname>Stephenson</surname>, <given-names>A. H.</given-names></string-name> (<year>2011</year>). <article-title>The Rho kinase inhibitor Y‐27632 increases erythrocyte deformability and low oxygen tension‐induced ATP release</article-title>. <source>American Journal of Physiology. Heart and Circulatory Physiology</source>, <volume>301</volume>(<issue>5</issue>), <fpage>H1891</fpage>–<lpage>H1896</lpage>.<pub-id pub-id-type="pmid">21890695</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0081">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0081"><string-name><surname>Vallance</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Collier</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Moncada</surname>, <given-names>S.</given-names></string-name> (<year>1989</year>). <article-title>Effects of endothelium‐derived nitric oxide on peripheral arteriolar tone in man</article-title>. <source>Lancet</source>, <volume>334</volume>(<issue>8670</issue>), <fpage>997</fpage>–<lpage>1000</lpage>.</mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0082">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0082"><collab collab-type="authors">WHO</collab>
(<year>1993</year>). <article-title>Aging and working capacity</article-title>. <source>World Health Organization Technical Report Series</source>, <volume>835</volume>, <fpage>1</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">8266710</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0083">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0083"><string-name><surname>Wickman</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Lan</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Vollrath</surname>, <given-names>B.</given-names></string-name> (<year>2003</year>). <article-title>Functional roles of the Rho/Rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: Relevance to subarachnoid hemorrhage and vasospasm</article-title>. <source>Circulation Research</source>, <volume>92</volume>(<issue>7</issue>), <fpage>809</fpage>–<lpage>816</lpage>.<pub-id pub-id-type="pmid">12637369</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0084">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0084"><string-name><surname>Wilkins</surname>, <given-names>B. W.</given-names></string-name>, <string-name><surname>Pike</surname>, <given-names>T. L.</given-names></string-name>, <string-name><surname>Martin</surname>, <given-names>E. A.</given-names></string-name>, <string-name><surname>Curry</surname>, <given-names>T. B.</given-names></string-name>, <string-name><surname>Ceridon</surname>, <given-names>M. L.</given-names></string-name>, &amp; <string-name><surname>Joyner</surname>, <given-names>M. J.</given-names></string-name> (<year>2008</year>). <article-title>Exercise intensity‐dependent contribution of beta‐adrenergic receptor‐mediated vasodilatation in hypoxic humans</article-title>. <source>Journal of Physiology</source>, <volume>586</volume>(<issue>4</issue>), <fpage>1195</fpage>–<lpage>1205</lpage>.<pub-id pub-id-type="pmid">18048452</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0085">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0085"><string-name><surname>Winter</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Dora</surname>, <given-names>K. A.</given-names></string-name> (<year>2007</year>). <article-title>Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries</article-title>. <source>Journal of Physiology</source>, <volume>582</volume>(<issue>1</issue>), <fpage>335</fpage>–<lpage>347</lpage>.<pub-id pub-id-type="pmid">17478526</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0086">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0086"><string-name><surname>Wray</surname>, <given-names>D. W.</given-names></string-name>, &amp; <string-name><surname>Richardson</surname>, <given-names>R. S.</given-names></string-name> (<year>2015</year>). “<article-title>Fine‐tuning” blood flow to the exercising muscle with advancing age: An update</article-title>. <source>Experimental Physiology</source>, <volume>100</volume>(<issue>6</issue>), <fpage>589</fpage>–<lpage>602</lpage>.<pub-id pub-id-type="pmid">25858164</pub-id></mixed-citation>
              </ref>
              <ref id="tjp15095-bib-0087">
                <mixed-citation publication-type="journal" id="tjp15095-cit-0087"><string-name><surname>Zhao</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ren</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Mao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name> (<year>2011</year>). <article-title>Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: Final results of a randomized trial of fasudil versus nimodipine</article-title>. <source>Neurologia Medico‐Chirurgica</source>, <volume>51</volume>(<issue>10</issue>), <fpage>679</fpage>–<lpage>683</lpage>.<pub-id pub-id-type="pmid">22027241</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
